<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2022-09-19T18:02:06Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:8594615" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:8594615</identifier>
        <datestamp>2021-12-07</datestamp>
        <setSpec>iai</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" dtd-version="1.3" xml:lang="en" article-type="research-article">
          <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
            <restricted-by>pmc</restricted-by>
          </processing-meta>
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Infect Immun</journal-id>
              <journal-id journal-id-type="iso-abbrev">Infect Immun</journal-id>
              <journal-id journal-id-type="publisher-id">IAI</journal-id>
              <journal-title-group>
                <journal-title>Infection and Immunity</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0019-9567</issn>
              <issn pub-type="epub">1098-5522</issn>
              <publisher>
                <publisher-name>American Society for Microbiology</publisher-name>
                <publisher-loc>1752 N St., N.W., Washington, DC</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC8594615</article-id>
              <article-id pub-id-type="pmcid">PMC8594615</article-id>
              <article-id pub-id-type="pmc-uid">8594615</article-id>
              <article-id pub-id-type="pmid">34125597</article-id>
              <article-id pub-id-type="pmid">34125597</article-id>
              <article-id pub-id-type="publisher-id">00304-21</article-id>
              <article-id pub-id-type="doi">10.1128/IAI.00304-21</article-id>
              <article-id pub-id-type="publisher-id">iai.00304-21</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Bacterial Infections</subject>
                </subj-group>
                <subj-group subj-group-type="biological-terms">
                  <compound-subject>
                    <compound-subject-part content-type="code">microbial-pathogenesis</compound-subject-part>
                    <compound-subject-part content-type="label">Microbial Pathogenesis</compound-subject-part>
                  </compound-subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Reinvestigating the Coughing Rat Model of Pertussis To Understand <italic toggle="yes">Bordetella pertussis</italic> Pathogenesis</article-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hall</surname>
                    <given-names>Jesse M.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0001-5736-0005</contrib-id>
                  <name>
                    <surname>Kang</surname>
                    <given-names>Jason</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kenney</surname>
                    <given-names>Sophia M.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wong</surname>
                    <given-names>Ting Y.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bitzer</surname>
                    <given-names>Graham J.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kelly</surname>
                    <given-names>Claire O.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Kisamore</surname>
                    <given-names>Caleb A.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Boehm</surname>
                    <given-names>Dylan T.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                  <xref rid="fn1" ref-type="author-notes">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>DeJong</surname>
                    <given-names>Megan A.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Wolf</surname>
                    <given-names>M. Allison</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Sen-Kilic</surname>
                    <given-names>Emel</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Horspool</surname>
                    <given-names>Alexander M.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Bevere</surname>
                    <given-names>Justin R.</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3250-3636</contrib-id>
                  <name>
                    <surname>Barbier</surname>
                    <given-names>Mariette</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                  <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-3140-402X</contrib-id>
                  <name>
                    <surname>Damron</surname>
                    <given-names>F. Heath</given-names>
                  </name>
                  <xref rid="aff1" ref-type="aff">
                    <sup>a</sup>
                  </xref>
                  <xref rid="aff2" ref-type="aff">
                    <sup>b</sup>
                  </xref>
                  <email>fdamron@hsc.wvu.edu</email>
                </contrib>
                <aff id="aff1">
                  <label>a</label>
                  <addr-line>Department of Microbiology, Immunology and Cell Biology, School of Medicine, <institution-wrap><institution>West Virginia University</institution><institution-id institution-id-type="grid">grid.268154.c</institution-id></institution-wrap>, Morgantown, West Virginia, USA</addr-line>
                </aff>
                <aff id="aff2">
                  <label>b</label>
                  <addr-line>Vaccine Development Center, WVU Health Sciences Center, Morgantown, West Virginia, USA</addr-line>
                </aff>
              </contrib-group>
              <contrib-group>
                <contrib contrib-type="editor">
                  <role>Editor</role>
                  <name>
                    <surname>Palmer</surname>
                    <given-names>Guy H.</given-names>
                  </name>
                  <aff>Washington State University</aff>
                </contrib>
              </contrib-group>
              <author-notes>
                <fn id="fn1" fn-type="present-address">
                  <label>*</label>
                  <p>Present address: Dylan T. Boehm, Vaccine and Gene Therapy Institute at Oregon Health Sciences University, 18 Beaverton, Oregon, USA.</p>
                </fn>
                <fn fn-type="other">
                  <p>For a companion article on this topic, see <ext-link xlink:href="https://doi.org/10.1128/IAI.00346-21" ext-link-type="uri">https://doi.org/10.1128/IAI.00346-21</ext-link>.</p>
                </fn>
                <fn fn-type="other">
                  <p><bold>Citation</bold> Hall JM, Kang J, Kenney SM, Wong TY, Bitzer GJ, Kelly CO, Kisamore CA, Boehm DT, DeJong MA, Wolf MA, Sen-Kilic E, Horspool AM, Bevere JR, Barbier M, Damron FH. 2021. Reinvestigating the coughing rat model of pertussis to understand <italic toggle="yes">Bordetella pertussis</italic> pathogenesis. Infect Immun 89:e00304-21. <ext-link xlink:href="https://doi.org/10.1128/IAI.00304-21" ext-link-type="uri">https://doi.org/10.1128/IAI.00304-21</ext-link>.</p>
                </fn>
              </author-notes>
              <pub-date publication-format="electronic" date-type="preprint">
                <day>14</day>
                <month>6</month>
                <year>2021</year>
              </pub-date>
              <pub-date publication-format="electronic" date-type="pub">
                <day>16</day>
                <month>11</month>
                <year>2021</year>
              </pub-date>
              <pub-date publication-format="electronic" date-type="collection">
                <month>12</month>
                <year>2021</year>
              </pub-date>
              <pub-date pub-type="pmc-release">
                <day>16</day>
                <month>11</month>
                <year>2021</year>
              </pub-date>
              <!--PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>.-->
              <volume>89</volume>
              <issue>12</issue>
              <elocation-id>e00304-21</elocation-id>
              <history>
                <date date-type="received">
                  <day>28</day>
                  <month>5</month>
                  <year>2021</year>
                </date>
                <date date-type="accepted">
                  <day>5</day>
                  <month>6</month>
                  <year>2021</year>
                </date>
              </history>
              <permissions>
                <copyright-statement>Copyright © 2021 Hall et al.</copyright-statement>
                <copyright-year>2021</copyright-year>
                <copyright-holder>Hall et al.</copyright-holder>
                <license>
                  <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
                  <license-p>This is an open-access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link>.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="iai.00304-21.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <p><named-content content-type="genus-species">Bordetella pertussis</named-content> is a highly contagious bacterium that is the causative agent of whooping cough (pertussis). Currently, acellular pertussis vaccines (aP, DTaP, and Tdap) are used to prevent pertussis disease. However, it is clear that the aP vaccine efficacy quickly wanes, resulting in the reemergence of pertussis. Furthermore, recent work performed by the CDC suggest that current circulating strains are genetically distinct from strains of the past. The emergence of genetically diverging strains, combined with waning aP vaccine efficacy, calls for reevaluation of current animal models of pertussis. In this study, we used the rat model of pertussis to compare two genetically divergent strains Tohama 1 and D420. We intranasally challenged 7-week-old Sprague-Dawley rats with 10<sup>8</sup> viable Tohama 1 and D420 and measured the hallmark signs/symptoms of <italic toggle="yes">B. pertussis</italic> infection such as neutrophilia, pulmonary inflammation, and paroxysmal cough using whole-body plethysmography. Onset of cough occurred between 2 and 4 days after <italic toggle="yes">B. pertussis</italic> challenge, averaging five coughs per 15 min, with peak coughing occurring at day 8 postinfection, averaging upward of 13 coughs per 15 min. However, we observed an increase of coughs in rats infected with clinical isolate D420 through 12 days postchallenge. The rats exhibited increased bronchial restriction following <italic toggle="yes">B. pertussis</italic> infection. Histology of the lung and flow cytometry confirm both cellular infiltration and pulmonary inflammation. D420 infection induced higher production of anti-<italic toggle="yes">B. pertussis</italic> IgM antibodies compared to Tohama 1 infection. The coughing rat model provides a way of characterizing disease manifestation differences between <italic toggle="yes">B. pertussis</italic> strains.</p>
              </abstract>
              <kwd-group>
                <title>KEYWORDS</title>
                <kwd>
                  <italic toggle="yes">Bordetella pertussis</italic>
                </kwd>
                <kwd>cough</kwd>
                <kwd>DTaP</kwd>
                <kwd>plethysmography</kwd>
                <kwd>rat</kwd>
              </kwd-group>
              <funding-group specific-use="FundRef">
                <award-group award-type="grant" id="award1">
                  <funding-source id="GS1">
                    <institution-wrap>
                      <institution>Division of Science and Research, WV Higher Education Policy Commission</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>HEPC.dsr.18.6</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Damron</surname>
                      <given-names>F. Heath</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group award-type="grant" id="award2">
                  <funding-source id="GS2">
                    <institution-wrap>
                      <institution>HHS | Centers for Disease Control and Prevention (CDC)</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000030</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>75D301-19-R-67835</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Damron</surname>
                      <given-names>F. Heath</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
                <award-group award-type="grant" id="award3">
                  <funding-source id="GS3">
                    <institution-wrap>
                      <institution>HHS | National Institutes of Health (NIH)</institution>
                      <institution-id institution-id-type="FundRef">https://doi.org/10.13039/100000002</institution-id>
                    </institution-wrap>
                  </funding-source>
                  <award-id>R01AI137155</award-id>
                  <principal-award-recipient>
                    <name>
                      <surname>Damron</surname>
                      <given-names>F. Heath</given-names>
                    </name>
                  </principal-award-recipient>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="10"/>
                <table-count count="0"/>
                <equation-count count="0"/>
                <ref-count count="71"/>
                <page-count count="18"/>
                <word-count count="11577"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>December 2021</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
          </front>
          <body>
            <sec sec-type="intro" id="s1">
              <title>INTRODUCTION</title>
              <p>Whooping cough (pertussis) is a respiratory disease that is caused by the bacterium <named-content content-type="genus-species">Bordetella pertussis</named-content>. Pertussis is characterized by severe leukocytosis, bronchopneumonia, hypoglycemia, and paroxysmal cough (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B2" ref-type="bibr">2</xref>). During the catarrhal stage, <italic toggle="yes">B. pertussis</italic> colonizes the upper respiratory epithelium. Once colonization occurs, <italic toggle="yes">B. pertussis</italic> releases toxins such as pertussis toxin (PT) and adenylate cyclase toxin (ACT), as well as others. The catarrhal stage is followed by the paroxysmal stage, which is characterized by severe coughing episodes. Innate and adaptive immune responses result in clearance of the bacterium, allowing for the patient or host to convalesce. Despite extensive research, a full understanding of <italic toggle="yes">B. pertussis</italic> pathogenesis remains elusive for reasons, such as vaccine pressure, a lack of predictive models, and strain evolution (<xref rid="B3" ref-type="bibr">3</xref>). One of the major reasons for this gap in knowledge is the lack of a suitable animal model that shares common disease symptoms as seen in humans. Besides nonhuman primates, rats are the only other known model of pertussis that share similar coughing manifestation as seen in humans (<xref rid="B4" ref-type="bibr">4</xref>). As of now, the origin or the trigger of the cough has yet to be determined (<xref rid="B5" ref-type="bibr">5</xref>). The rat model of pertussis offers a potential animal model that can be used to evaluate <italic toggle="yes">B. pertussis</italic> pathogenesis.</p>
              <p>In 1938, Hornibrook and Ashburn were the first to report that rats infected with <italic toggle="yes">B. pertussis</italic> induced cough-like paroxysms and bronchopneumonia, as seen in humans (<xref rid="B6" ref-type="bibr">6</xref>). Hornibrook and Ashburn found that young rats could be infected and the bacterium could be cultured from the lungs (<xref rid="B6" ref-type="bibr">6</xref>). Infected rats produced coughs that could be heard from a distance of 20 feet (<xref rid="B6" ref-type="bibr">6</xref>). Of the 31 infected rats, 26 that did not succumb to the infection had pathology indicative of inflammation in the lungs, most notably early neutrophil infiltration, followed by recruitment of mononuclear cells (<xref rid="B6" ref-type="bibr">6</xref>). The subsequent studies utilized intrabronchial inoculation of <italic toggle="yes">B. pertussis</italic> encased in agar beads and confirmed leukocytosis and paroxysmal cough by sound activated tape recorders from 5 to 21 days postchallenge (<xref rid="B7" ref-type="bibr">7</xref>, <xref rid="B8" ref-type="bibr">8</xref>). Further development of the rat model led to the evaluation of PT-negative strains and the evaluation of coughs (<xref rid="B9" ref-type="bibr">9</xref>). Strain BP357, which is deficient in PT resulted in low cough induction (<xref rid="B9" ref-type="bibr">9</xref>). Further evaluation of the rat model demonstrated leukocytosis, weight loss, and paroxysmal cough in Sprague-Dawley rats during the course of <italic toggle="yes">B. pertussis</italic> infection (<xref rid="B10" ref-type="bibr">10</xref>). During the development phase of the acellular pertussis vaccine (aP and DTaP), the rat model was used to test vaccine efficacy of various acellular pertussis formulations and was used to validate protection against the onset of leukocytosis and cough (<xref rid="B11" ref-type="bibr">11</xref>). Recently, an intranasal rat model has been used to evaluate bacterial factors responsible for cough in <named-content content-type="genus-species">Bordetella bronchiseptica</named-content> (<xref rid="B12" ref-type="bibr">12</xref>). BspR, which is an anti-sigma factor of <italic toggle="yes">B. bronchiseptica</italic>, plays some role in cough induction upon infection (<xref rid="B12" ref-type="bibr">12</xref>). Collectively, these studies show that the pertussis rat model can be used to critically evaluate <italic toggle="yes">B. pertussis</italic> pathogenesis and disease progression.</p>
              <p>In the 1940s, whole-cell pertussis (wP and DTP) vaccines were introduced to protect against <italic toggle="yes">B. pertussis</italic> infection (<xref rid="B13" ref-type="bibr">13</xref>). Widespread use of DTP in the United States led to a 90% decrease in the number of reported <italic toggle="yes">B. pertussis</italic> infections (<xref rid="B13" ref-type="bibr">13</xref>). Despite the efficacy of this vaccine, serious adverse side effects ensued, leading to the development of acellular pertussis vaccines. The antigens that are included in the current aP vaccines contain: filamentous hemagglutinin (FHA), fimbriae (FIM), PT, and pertactin (PRN). After the switch from the wP to the aP vaccines, there has been a significant increase in the number of pertussis cases in the United States and Europe (<xref rid="B14" ref-type="bibr">14</xref>). While nationwide vaccine coverage is 95% in the United States, the incidence of <italic toggle="yes">B. pertussis</italic> infections rose in the past 10 years as the number of aP-vaccinated-only population has increased in size. (<xref rid="B15" ref-type="bibr">15</xref>). While vaccine coverage remains high, the population dynamics are changing, and more people are aP immunized as the new generations are born and as the wP-only generations age. Numerous studies have demonstrated waning efficacy of aP vaccines in parallel with the emergence of genetically divergent strains of <italic toggle="yes">B. pertussis</italic> (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B16" ref-type="bibr">16</xref><xref rid="B17" ref-type="bibr">–</xref><xref rid="B21" ref-type="bibr">21</xref>). Increased surveillance of <italic toggle="yes">B. pertussis</italic> has led to the identification of clinical isolates that do not express PRN, FIM, and even PT, the hallmark toxin of the organism (<xref rid="B22" ref-type="bibr">22</xref>). One plausible hypothesis to explain these observations is that circulating <italic toggle="yes">B. pertussis</italic> strains have evolved due to acellular vaccine pressure. While we know the current strains are genetically different, we do not know whether this genetic variability affects the virulence, disease burden, toxicity, or fitness of the pathogen (<xref rid="B3" ref-type="bibr">3</xref>).</p>
              <p>Early rat studies were performed with intranasal administration of <italic toggle="yes">B. pertussis</italic> for infection (<xref rid="B6" ref-type="bibr">6</xref>). Subsequent rat challenge studies used <italic toggle="yes">B. pertussis</italic> encased in agar beads for intrabronchial instillation (<xref rid="B7" ref-type="bibr">7</xref><xref rid="B8" ref-type="bibr">–</xref><xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B23" ref-type="bibr">23</xref>). While the agar bead infection method was successful at establishing infection, we aimed to utilize the simplicity of intranasal administration. We sought to reinvestigate the coughing rat model of pertussis to compare the pathogenesis of reference strain Tohama 1 to the recent clinical isolate D420, which has been extensively studied in the baboon model of pertussis (<xref rid="B24" ref-type="bibr">24</xref><xref rid="B25" ref-type="bibr">–</xref><xref rid="B30" ref-type="bibr">30</xref>). Tohama 1 was first isolated from a case of whooping cough in 1954, while D420 was isolated in 2002 from a critically ill infant in Texas (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B31" ref-type="bibr">31</xref>). Although Tohama 1 is now a reference strain that has been widely used since Sato and Sato developed the aP, but recent data have shown that this strain is an considered an outlier (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Tohama 1 does express PRN but has lower expression of PT and ACT (<xref rid="B34" ref-type="bibr">34</xref>). When Tohama 1 was used as a challenge strain in baboons, the baboons did not exhibit symptoms of pertussis despite being infected (<xref rid="B26" ref-type="bibr">26</xref>). This led to the selection of recent clinical isolate D420 as the baboon challenge strain, which readily infected and caused disease (<xref rid="B26" ref-type="bibr">26</xref>). With 48 years of potential genetic divergence, we sought to understand the differences in pathogenesis between these two commonly studied strains. D420 is known to infect mice and baboons, and it belongs to the clade (CDC013) of strains that represented 50% of isolates recovered in the United States in 2000 (<xref rid="B3" ref-type="bibr">3</xref>). However, it is important to note that D420 has an intact pertactin gene, and it does express the PRN protein, as confirmed by shotgun proteomic analysis (data not shown).</p>
              <p>In the present study, we aimed to reestablish an upper respiratory tract infection model in rats following intranasal challenge with Tohama I and D420. We hypothesized that the recent isolate D420 would induce a more severe disease profile compared to Tohama 1, since previous research investigating pathogenesis in rhesus macaques noted that Tohama 1-infected animals did not exhibit overt disease symptoms (<xref rid="B26" ref-type="bibr">26</xref>). Sprague-Dawley rats were intranasally challenged with <italic toggle="yes">B. pertussis</italic>, and we characterized their disease progression profile over a 12-day infection. Cough was critically assessed utilizing whole-body plethysmography (WBP). Bacterial colonization, leukocytosis, and serological responses were measured as a result of infection. Rats challenged with D420 had increased coughing, greater bacterial burden in the respiratory tract, and a more robust IgM antibody response compared to rats challenged with Tohama 1. The coughing rat model of pertussis can shed light on the pathogenesis of <italic toggle="yes">B. pertussis</italic> and will likely be a useful tool for pertussis vaccine evaluation.</p>
            </sec>
            <sec sec-type="results" id="s2">
              <title>RESULTS</title>
              <sec id="s2-1">
                <title>D420-infected rats have increased number of coughs compared to strain Tohama 1 over the entire course of infection.</title>
                <p>Over the past decade it has become clear that improvements to the acellular pertussis vaccine strategy are needed due to the increases in PRN mutants, genomic divergence, and epidemiological data. We believe that in order to improve pertussis vaccines we need to better understand the pathogenesis of <italic toggle="yes">B. pertussis</italic> in an animal model that shares similar clinical manifestations of pertussis seen in humans. Here, we intranasally infected 7-week-old Sprague-Dawley rats with 10<sup>8</sup> CFU of <italic toggle="yes">B. pertussis</italic> strain D420 or Tohama 1 (<xref rid="F1" ref-type="fig">Fig. 1</xref>) in an effort establish infection and observe <italic toggle="yes">B. pertussis</italic> induced cough. For negative controls (no bacterial challenge), rats were intranasally administered sterile phosphate-buffered saline (PBS). Paroxysmal cough is the hallmark symptom of pertussis and is thought to play a major role in transmission of the organism to a new host. To quantify respiratory function during infection, we utilized whole-body plethysmography (WBP). WBP instrumentation consists of specialized containment chambers which monitor box flow, temperature, and airflow changes to measure respiratory function. Counting coughs via WBP provides an extremely accurate and unbiased way of counting coughs based on cough waveforms. Rat containment chambers were placed inside a laminar flow hood and connected to a computer that would monitor the rats breathing (see Fig. S1). Early studies reported that <italic toggle="yes">B. pertussis</italic> infection in young rats induced coughs that were audible by ear (<xref rid="B6" ref-type="bibr">6</xref>), and in our preliminary studies this was apparent to us as well (data not shown). Studies in the 1990s of paroxysmal cough in rats were quantified using an analog sound recording device (<xref rid="B7" ref-type="bibr">7</xref>). We hypothesized that rats infected with the recent isolate D420 would induce more coughs than animals infected with the reference strain Tohama 1 because rhesus macaques infected with Tohama 1 did not exhibit overt disease symptoms but D420 induced robust coughing in baboons (<xref rid="B26" ref-type="bibr">26</xref>). <italic toggle="yes">B. pertussis</italic>-infected rats developed cough at days 2 to 11 (<xref rid="F2" ref-type="fig">Fig. 2B</xref> and <xref rid="F2" ref-type="fig">C</xref>), while mock-infected rats (<xref rid="F2" ref-type="fig">Fig. 2A</xref>) only had a few isolated coughs, unrelated to infection. At days 1 to 3 postinfection, the average cough count for rats infected with Tohama 1 or D420 was fewer than 5 coughs per 15 min. The average cough count doubled by day 7 postinfection, with peak coughing occurring at day 8 postinfection and with an average of 13 coughs per 15 min of monitoring. After day 8, the average cough count for rats infected with D420 remained above 10 coughs per 15 min, while the rats infected with Tohama 1 averaged fewer than 5 coughs. To summarize the cough data, the average cough count over the course of infection is shown (<xref rid="F2" ref-type="fig">Fig. 2D</xref>). We observed a significant increase in the number of coughs at day 8 postinfection of <italic toggle="yes">B. pertussis</italic>-infected rats compared to the mock-infected challenge control. Rats infected with D420 coughed a total of 949 times, whereas rats infected with Tohama 1 coughed a total of 724 times over the entire 12-day infection. To analyze differences in cough count between strains, we utilized area under the curve (AUC) analysis (<xref rid="F2" ref-type="fig">Fig. 2E</xref>). AUC analysis allows us to quantify the number of coughs over the entire course of infection per rat. Using this analysis approach, we note a significant increase in the number of coughs for rats infected with D420 compared to the mock-challenged rats over the 12-day infection, while there was no significant difference observed in Tohama 1-infected rats compared to mock-challenged rats (noninfected).</p>
                <fig position="float" id="F1">
                  <label>FIG 1</label>
                  <caption>
                    <p>Experimental design of intranasal infection of <italic toggle="yes">B. pertussis</italic>. Schematic representation of Sprague-Dawley rats intranasally infected with <italic toggle="yes">B. pertussis</italic>. Whole-body plethysmography was used to measure cough and analyze lung function over the course of a 12-day infection. Body weight, bacterial burden of the respiratory tract, innate lymphoid recruitment, and antibody titers were measured at the days 1, 3, 6, 9, and 12 postchallenge. The left lobe of the lung and the NALT were sectioned and stained with H&amp;E for histological analysis, and immunohistochemistry was performed to visualize the bacteria in the left lobe of the lung and nasal cavity. (<xref rid="F1" ref-type="fig">Figure 1</xref> was created with BioRender.com.)</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f001" position="float"/>
                </fig>
                <fig position="float" id="F2">
                  <label>FIG 2</label>
                  <caption>
                    <p>Infection of <named-content content-type="genus-species">B. pertussis</named-content> induces cough in Sprague-Dawley rats. Coughs were measured each day of the 12-day infection using whole-body plethysmography. Coughs were counted for mock challenge rats (A), rats infected with D420 (B), and rats infected with Tohama 1 (C). (D) Summary of results (see panels A to C) shown as means ± the standard errors of the mean (SEM; <italic toggle="yes">n </italic>= 4 to 8). (E) AUC, represented as averages of coughs per 15 min for each rat. <italic toggle="yes">P</italic> values were determined by two-way ANOVA, followed by a Bonferroni comparison test and an unpaired Student <italic toggle="yes">t</italic> test for AUC (*, <italic toggle="yes">P &lt; </italic>0.05 [D420 compared to the mock-challenged control group], #, <italic toggle="yes">P</italic> &lt; 0.05 [Tohama 1 compared to the mock challenged control group]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f002" position="float"/>
                </fig>
              </sec>
              <sec id="s2-2">
                <title><italic toggle="yes">B. pertussis</italic> infection causes pulmonary distress.</title>
                <p>Infection with <italic toggle="yes">B. pertussis</italic> leads to mucus production, lung damage, and invasion of cellular infiltrates into the bronchioles of the lung (<xref rid="B35" ref-type="bibr">35</xref>). The lungs of infants with <italic toggle="yes">B. pertussis</italic> exhibit edema, necrotizing bronchiolitis, and inflammation in the lung leading to respiratory distress (<xref rid="B35" ref-type="bibr">35</xref>). WBP was used to quantify the pulmonary distress over the course of infection. Pulmonary distress was measured by calculating the enhanced pause (PenH) of the animal (<xref rid="F3" ref-type="fig">Fig. 3</xref>). The higher the PenH value, the increased respiratory distress of the animal. PenH corresponds to the resistance associated with peak inspiratory height and peak expiratory height and taking into account time between early and late expiration per breath (see Fig. S2). With increased constriction, the expiratory peak becomes prominent and the area of the peak expiratory height becomes a larger percentage of the complete expiratory area. Other factors that contribute to the increased PenH is a decrease in relaxation time (Tr) in relation to expiratory time (Te). Previous research has shown that severe inflammation in the lungs of mice directly correlated with an increase in PenH (<xref rid="B36" ref-type="bibr">36</xref>). More recently, SARS-CoV-2 infected mice were observed to have subtle but significant increase in PenH postchallenge (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B38" ref-type="bibr">38</xref>). Compared to the mock-challenged rats, both D420- and Tohama 1-infected rats displayed an increase in PenH (<xref rid="F3" ref-type="fig">Fig. 3</xref>). We observed a significant increase at day 9 with rats infected with D420 and at day 6 with rats infected with Tohama 1 compared to mock-challenged rats.</p>
                <fig position="float" id="F3">
                  <label>FIG 3</label>
                  <caption>
                    <p><named-content content-type="genus-species">B. pertussis</named-content> infection impairs respiratory capacity. Over the course of infection, Sprague-Dawley rat respiratory function was analyzed using whole-body plethysmography. Each day at 5 p.m., rat bronchial restriction was determined utilizing WBP to calculate the PenH. The results are shown as means ± the SEM (<italic toggle="yes">n</italic> = 4 to 8). <italic toggle="yes">P</italic> values were determined by two-way ANOVA, followed by Dunnett’s comparison test (*, <italic toggle="yes">P &lt; </italic>0.05; *<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.01 [compared to the mock challenge group]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f003" position="float"/>
                </fig>
              </sec>
              <sec id="s2-3">
                <title>Histological assessment of the lung and nasal cavity.</title>
                <p>To further evaluate the inflammation in the lung, we utilized histology to confirm both acute and chronic inflammation in response to <italic toggle="yes">B. pertussis</italic> infection. At days 1, 3, 6, 9, and 12 postchallenge, the left lobes were collected, sectioned, and stained with hematoxylin and eosin (H&amp;E) (<xref rid="F4" ref-type="fig">Fig. 4A</xref> and <xref rid="F4" ref-type="fig">C</xref>). Whole-lung images were taken to assess cellular infiltration (see Fig. S3). Once stained, the blinded slides were then scored by a board-certified pathologist. Mock-challenged animals exhibited minimal inflammatory infiltrates consisting of focal accumulations of mononuclear cells in the parenchyma and occasional infiltrates of neutrophils surrounding blood vessels (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). Rats infected with Tohama 1 and D420 showed significant increases in their acute inflammation scores compared to mock-challenged animals at days 1 and 3 postinfection (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). The highest acute inflammation score occurred at day 1 postinfection (<xref rid="F4" ref-type="fig">Fig. 4B</xref>). Rats exhibited mild to moderate neutrophil infiltration of the parenchyma, blood vessels, and bronchioles (<xref rid="F4" ref-type="fig">Fig. 4A</xref>). Markers of acute inflammation resolved after day 6 postchallenge; however, infected rats at day 9 exhibited obvious differences in the lungs associated with mild to moderate infiltration of mononuclear cells and higher chronic inflammation compared to mock-challenged animals (<xref rid="F4" ref-type="fig">Fig. 4C</xref>). At day 12 postinfection, we notice moderate resolution of inflammation in both D420- and Tohama 1-infected rats (<xref rid="F4" ref-type="fig">Fig. 4B</xref> and <xref rid="F4" ref-type="fig">D</xref>). We also observed a significant increase in lung weight, which can be associated with elevated inflammation, at days 1 and 9 postchallenge in D420-infected rats compared to the mock-challenged controls (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). At day 12 postchallenge, rats infected with Tohama 1 showed a significant increase in lung weight compared to the mock-challenged rats (<xref rid="F5" ref-type="fig">Fig. 5A</xref>). These results confirm that <italic toggle="yes">B. pertussis</italic> infection induces inflammation in the lungs of coughing Sprague-Dawley rats.</p>
                <fig position="float" id="F4">
                  <label>FIG 4</label>
                  <caption>
                    <p><italic toggle="yes">B. pertussis</italic> infection induces acute and chronic inflammation in the lungs of Sprague-Dawley rats. The left lobe of the lung was sectioned and stained with H&amp;E from rats infected with D420 or Tohama 1 or from the PBS control. (A) Representative images of acute inflammation demonstrating neutrophil recruitment around surrounding blood vessel (asterisk) and parenchyma (arrows) at ×400 magnification. (B) Average acute inflammatory score of the lung based on the predominance of neutrophils in the parenchyma, blood vessels, and airways. (C) Representative images of chronic inflammation showing mononuclear cells surrounding the blood vessel (asterisk), lamina propria (arrow), and bronchioles (arrowhead) at ×200 magnification. (D) Average chronic inflammatory score of the lungs characterized by mononuclear infiltrates in the parenchyma, blood vessels, and airway. Histological assessment was determined blinded with no knowledge of the treatment groups. The results are shown as means ± the SEM (<italic toggle="yes">n</italic> = 4). <italic toggle="yes">P</italic> values were determined by one-way ANOVA, followed by Dunnett’s comparison test (*, <italic toggle="yes">P &lt; </italic>0.05 [compared between challenge groups]; #, <italic toggle="yes">P &lt; </italic>0.05, ##, <italic toggle="yes">P &lt; </italic>0.01 [compared to mock challenge]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f004" position="float"/>
                </fig>
                <fig position="float" id="F5">
                  <label>FIG 5</label>
                  <caption>
                    <p><italic toggle="yes">B. pertussis</italic> infection induces inflammation of the lung and a decrease in weight gain. (A) After euthanasia, the lung weight was measured and recorded. To observe any weight changes over the course of infection, we calculated the percent weight change for mock-challenged (B), D420-infected (C), and Tohama 1-infected (D) rats. Rat body weights were recorded before infection, as well as immediately posteuthanasia. The percent weight change was calculated by taking the differences between starting weight and end weight and dividing by the initial weight and then multiplying by 100. Results are shown as means ± the SEM (<italic toggle="yes">n</italic> = 1 to 4). Only one mock-challenge rat weight was measured at days 1, 3, 6, and 9. Weights of 4 mock-challenge rats were recorded at day 12 postinfection. <italic toggle="yes">P</italic> values were determined by one-way ANOVA (*, <italic toggle="yes">P</italic> &lt; 0.05; *<italic toggle="yes">*</italic>, <italic toggle="yes">P</italic> &lt; 0.01; **<italic toggle="yes">*</italic>, <italic toggle="yes">P</italic> &lt; 0.001 [(A) compared to mock-challenge group; (B to D) compared to both infection groups]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f005" position="float"/>
                </fig>
                <p>Due to the fact that <italic toggle="yes">B. pertussis</italic> is a mucosal pathogen, we sought out to investigate any phenotypic changes or inflammation in the nasal-associated lymphoid tissues (NALT) of <italic toggle="yes">B. pertussis</italic>-infected rats via histology. NALT helps elicit immunity against airborne and mucosal pathogens (<xref rid="B39" ref-type="bibr">39</xref>). The NALT is located above the hard palate, and studies have also shown that with the introduction of antigen via vaccination or bacterial components, cellular expansion of the NALT ensues (<xref rid="B40" ref-type="bibr">40</xref><xref rid="B41" ref-type="bibr">–</xref><xref rid="B44" ref-type="bibr">44</xref>). The NALT was stained with H&amp;E, and we observed an increase in cellular infiltrate and a size enlargement in the NALT of <italic toggle="yes">B. pertussis</italic>-infected rats compared to the mock-challenged rats (<xref rid="F6" ref-type="fig">Fig. 6A</xref>). ImageJ analysis was used to measure the area of both the left and right NALT of each animal (<xref rid="F6" ref-type="fig">Fig. 6B</xref>). These data could mark the potential cellular expansion of the NALT upon infection with <italic toggle="yes">B. pertussis</italic>. Further analysis of the expanding cell populations in the NALT will warrant more analysis especially in the context of vaccine immunity.</p>
                <fig position="float" id="F6">
                  <label>FIG 6</label>
                  <caption>
                    <p>Analysis of the nasal associated lymphoid tissue (NALT). The skull was sectioned, allowing staining of the NALT with H&amp;E. (A) Representative 20× images of the NALT. Arrows indicate the NALT. (B) ImageJ analysis of the area of both left and right NALT. The dotted line represents the average area of the NALT in the mock-challenged group. Results are shown as means ± the SEM (<italic toggle="yes">n </italic>=<italic toggle="yes"> </italic>4). <italic toggle="yes">P</italic> values were determined by two-way ANOVA (*, <italic toggle="yes">P &lt; </italic>0.05; **<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.001; ***<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.0001 [compared to the mock-challenge group]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f006" position="float"/>
                </fig>
              </sec>
              <sec id="s2-4">
                <title>D420-infected rats demonstrate an increased bacterial burden in the respiratory tract.</title>
                <p>We determined the bacterial burden in the respiratory tract for Tohama I- and D420-challenged rats at days 1, 3, 6, 9, and 12. Over the coughing timeline, we observed an overall decrease in viable bacteria in the lung, trachea, and nasal cavity. In the lung, we observed a significant increase in the recovered bacteria in D420-infected rats compared to Tohama 1-infected rats at both days 1 and 3 (<xref rid="F7" ref-type="fig">Fig. 7A</xref>). The same trend is also seen in the nasal cavity at day 1 postinfection (<xref rid="F7" ref-type="fig">Fig. 7C</xref>). We observed no difference in the viable bacteria recovered from the trachea (<xref rid="F7" ref-type="fig">Fig. 7B</xref>). Previous pertussis studies utilizing the rat model of pertussis noted weight loss from intrabronchial infection of <italic toggle="yes">B. pertussis</italic> strain 18-323 (<xref rid="B10" ref-type="bibr">10</xref>). <italic toggle="yes">B. pertussis</italic> infection is sufficient to cause weight loss in rats (<xref rid="B10" ref-type="bibr">10</xref>). To confirm this using intranasal infection, body weights were measured before challenge and upon euthanasia to calculate the percent weight change. We observed a significant decrease in weight gain in rats infected with <italic toggle="yes">B. pertussis</italic> strain D420 and Tohama 1 compared to the mock-challenged animals at day 12 postinfection (<xref rid="F5" ref-type="fig">Fig. 5B</xref> to <xref rid="F5" ref-type="fig">D</xref>).</p>
                <fig position="float" id="F7">
                  <label>FIG 7</label>
                  <caption>
                    <p>Analysis of bacterial burden over the course of <italic toggle="yes">B. pertussis</italic> infection. Bacteria were quantified by serially diluted CFU following intranasal challenge. CFU counts were determined from lung homogenate (A), trachea (B), and nasal lavage (C). The results are shown as means ± the SEM (<italic toggle="yes">n </italic>=<italic toggle="yes"> </italic>4). <italic toggle="yes">P</italic> values were determined by two-way ANOVA corrected with the Bonferroni comparison test (*, <italic toggle="yes">P &lt; </italic>0.05; *<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.01; ***<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.0001 [compared between D420 and Tohama 1]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f007" position="float"/>
                </fig>
                <p>Next, we aimed to compare the bacterial colonization between outbred mice and rats in an effort to relatively compare the bacterial burden between models. We utilized the bacterial burden data in CD1 mice and compared them to our data in rats (<xref rid="B45" ref-type="bibr">45</xref>). To address the body weight differences between the mice and rats, we used the CFU/organ and divided these values by their respective body weights for a crude comparison. Our data suggest that despite having a higher initial challenge dose in the rat, the bacterial burden remaining in the respiratory tract is higher in a mouse compared to a rat later during infection (see Fig. S4). In general, the rat model is likely a lower challenge dose per body weight model of pertussis compared to mouse models.</p>
              </sec>
              <sec id="s2-5">
                <title>Immunofluorescence confirms colonization of <italic toggle="yes">B. pertussis</italic> in the lungs and nasal cavity.</title>
                <p>We next wanted to assess the location of bacterial colonization in the nasal cavity and visualize any bacteria left behind following flushing of the nares. We sectioned the skulls after flushing the nasal cavity and utilized immunofluorescence (IF). After visually scanning the nasal cavity using confocal microscopy, we found bacteria in the nasal turbinates and the NALT (<xref rid="F8" ref-type="fig">Fig. 8A</xref> and <xref rid="F8" ref-type="fig">C</xref>). We also confirmed that the bacteria were found between the epithelial cells (<xref rid="F8" ref-type="fig">Fig. 8B</xref>). The relative locations where the bacteria were found in the nasal cavity can be seen in Fig. S5A in the supplemental material. Our results show that <italic toggle="yes">B. pertussis</italic> remained in the nasal cavity over the entire course of infection even after flushing the nares (see Fig. S5B). The flushing of the nasal cavity underrepresents the total number of <italic toggle="yes">B. pertussis</italic> in the nasal cavity. In the lung, <italic toggle="yes">B. pertussis</italic> colonizes the bronchioles, while the alveolar spaces remain noncolonized (<xref rid="F8" ref-type="fig">Fig. 8D</xref> and <xref rid="F8" ref-type="fig">F</xref>). IF was performed on the nasal cavities and lungs of mock-challenged animals to access nonspecific binding (see Fig. S6). To assess any potential differences between the strains we blindly manually counted the labeled microcolonies in the lung and nasal cavity. It is also worthy to note, we found no differences in microcolony counts in the lung or nasal cavity between the strains (see Fig. S5C and D) despite our observed differences in bacterial burden by CFU enumeration. CFU is likely a better indicator of overall bacterial burden, but IF revealed that some <italic toggle="yes">B. pertussis</italic> remains in the airway following flushing of the nares.</p>
                <fig position="float" id="F8">
                  <label>FIG 8</label>
                  <caption>
                    <p>Immunofluorescence (IF) staining of <italic toggle="yes">B. pertussis</italic> localization in the respiratory tract. <italic toggle="yes">B. pertussis</italic> was labeled using a polyclonal antibody to FHA and counter-tagged with a fluorescently conjugated antibody (Texas Red). Sections were counterstained with DAPI. (A to C) Representative images of <italic toggle="yes">B. pertussis</italic> in the nasal cavity over the course of infection. <italic toggle="yes">B. pertussis</italic> was found captured in the cilia of the nasal cavity, as well as of the NALT. (D and E) Representative images of the bronchioles and alveoli of infected rats. <italic toggle="yes">B. pertussis</italic> was found localized in the bronchioles over the course of infection and absent in the alveoli.</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f008" position="float"/>
                </fig>
              </sec>
              <sec id="s2-6">
                <title>Measurement of recruitment of neutrophils in response to <italic toggle="yes">B. pertussis</italic> infection.</title>
                <p>Previous studies utilizing the rat model of pertussis noted leukocytosis and an increase in the number of total white blood cells when agar-encased <italic toggle="yes">B. pertussis</italic> was used for infection (<xref rid="B8" ref-type="bibr">8</xref>). Neutrophils circulating through the blood were measured during intranasal infection by antibody staining and flow cytometry, since <italic toggle="yes">B. pertussis</italic> infection results in various amounts of neutrophilia (<xref rid="B35" ref-type="bibr">35</xref>, <xref rid="B46" ref-type="bibr">46</xref>). One caveat in analyzing cell populations via flow cytometry in the rats is the limited availability of rat specific antibodies compared to mice. Recent research by Barnett-Vanes et al. has developed a flow cytometry panel to analyze cell populations in a model of lipopolysaccharide-induced pulmonary inflammation (<xref rid="B47" ref-type="bibr">47</xref>). The percentages of CD45<sup>+</sup> (CD161<sup>−</sup> B220<sup>−</sup> CD43<sup>+</sup> His48<sup>Hi</sup>) neutrophils in the blood were assessed in <italic toggle="yes">B. pertussis</italic>-infected rats compared to mock-challenged animals (<xref rid="F9" ref-type="fig">Fig. 9A</xref>). Specifically, a significant increase was observed in the number of circulating neutrophils in the blood of rats infected with D420 at days 1 and 9, with Tohama 1-infected rats only having a significant increase in response to mock challenge at day 9 (<xref rid="F9" ref-type="fig">Fig. 9A</xref>). Next, cytokine concentrations in the lung and serum were measured to identify factors that could contribute to the recruitment of neutrophils, specifically interleukin-6 (IL-6) and IL-17. IL-6 is a potent inducer of Th17 polarization and has been found elevated during murine infection with <italic toggle="yes">B. pertussis</italic> (<xref rid="B45" ref-type="bibr">45</xref>, <xref rid="B48" ref-type="bibr">48</xref><xref rid="B49" ref-type="bibr">–</xref><xref rid="B50" ref-type="bibr">50</xref>). Surprisingly, we did not observe any significant changes in IL-6 due to <italic toggle="yes">B. pertussis</italic> infection (<xref rid="F9" ref-type="fig">Fig. 9B</xref> and <xref rid="F9" ref-type="fig">C</xref>). It has been well documented in the mouse model that the production of IL-17 in pertussis plays a role in the increase in circulating neutrophils (<xref rid="B51" ref-type="bibr">51</xref>). There were no significant changes in IL-17a in the sera or lungs of <italic toggle="yes">B. pertussis</italic>-infected rats compared to mock-challenged rats (<xref rid="F9" ref-type="fig">Fig. 9D</xref> and <xref rid="F9" ref-type="fig">E</xref>). Th1 and Th2 cytokines and chemokines in the lung and serum were also measured (see Fig. S7 to S10). We did not observe an increase in the induction of cytokines by infection overall; however, in the serum, rats infected with D420 had a significant increase in IL-5 compared to Tohama 1-infected rats at day 12 postinfection (see Fig. S7). There was a significant increase in IL-5 and TNF-α at day 6 postinfection in the lung in rats infected with Tohama 1 compared to D420 (see Fig. S8). We also observed significant increases in chemokines MIP-1a, RANTES, MCP-3, MIP-2, and IP10 in rats infected with D420 at day 12 postchallenge in the serum compared to rats infected with Tohama 1 (see Fig. S19). In the lung, MIP-2 and IP10 were increased in rats infected with D420 compared to the mock-challenged controls (see Fig. S10). Despite slight differences highlighted above we did not observe a massive difference in the cytokine and chemokine responses during infection.</p>
                <fig position="float" id="F9">
                  <label>FIG 9</label>
                  <caption>
                    <p>Neutrophil recruitment and proinflammatory cytokine production after challenge determined by flow cytometry and multiplex immunoassay analysis. (A) Blood neutrophil count of Sprague-Dawley rats infected with <named-content content-type="genus-species">Bordetella pertussis</named-content>. At days 1, 3, 6, 9, and 12 postinfection, rats were euthanized, and blood was collected via cardiac puncture. Flow cytometry was used to quantify the amount of neutrophils (CD45<sup>+</sup> CD161<sup>−</sup> B220<sup>–</sup> CD43<sup>+</sup> His48<sup>hi</sup>) in the blood. Quantification of the percentage of single, CD45<sup>+</sup> cells was performed. The dotted line represents the average frequency of CD45<sup>+</sup> neutrophils in the mock challenge animals over the course of the study. (B and C) Analysis of cytokine IL-6 from the supernatant of lung homogenate and serum. (D and E) Analysis of cytokine IL-17 in serum and lung homogenate supernatant. Cytokines were analyzed using a ProcartaPlex multiplex immunoassay kit. Results are shown as means ± the SEM (<italic toggle="yes">n </italic>=<italic toggle="yes"> </italic>4). The dotted line represents the average mock-challenged cytokine levels measured. <italic toggle="yes">P</italic> values were determined by one-way ANOVA, followed by a Tukey comparison test (#, <italic toggle="yes">P</italic> &lt; 0.05; ##, <italic toggle="yes">P</italic> &lt; 0.01; ####, <italic toggle="yes">P</italic> &lt; 0.0001 [compared to mock challenge]).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f009" position="float"/>
                </fig>
              </sec>
              <sec id="s2-7">
                <title>Serological analysis of <italic toggle="yes">B. pertussis</italic>-specific antibodies.</title>
                <p>Enzyme-linked immunosorbent assays (ELISAs) were performed to determine the serological response generated from <italic toggle="yes">B. pertussis</italic> infection. We measured IgM and IgG antibody titers in the serum to whole bacterium and <italic toggle="yes">B. pertussis</italic>-associated virulence factors at days 1, 3, 6, 9, and 12 postinfection. In previous studies utilizing the rat model, intrabronchial infection induced the generation of IgG antibody titers to sonicated <italic toggle="yes">B. pertussis</italic> at 28 days postinfection (<xref rid="B8" ref-type="bibr">8</xref>). Intranasal infection of strain D420 has generated significant anti-PT IgG antibody titers in the baboon model at days 17 to 19 postinfection (<xref rid="B26" ref-type="bibr">26</xref>). However, analysis of antibody titers generated against an intranasal pertussis infection in the rat has yet to be determined, and we wanted to characterize the primary antibody response to <italic toggle="yes">B. pertussis</italic> (see Fig. S11). We observed a significant 10-fold increase in the anti-<italic toggle="yes">B. pertussis</italic> IgM antibody response at day 9 and an almost 20-fold increase 12 days postchallenge in rats infected with D420 compared to the mock challenge, while we also saw a significant 6-fold increase in anti-<italic toggle="yes">B. pertussis</italic> IgM at day 12 postinfection compared to the amount of anti-<italic toggle="yes">B. pertussis</italic> IgM from Tohama 1 infection (<xref rid="F10" ref-type="fig">Fig. 10A</xref>). At day 12 postinfection, we observed that the <italic toggle="yes">B. pertussis</italic> infection induced significant production of anti-<italic toggle="yes">B. pertussis</italic> IgG in the serum compared to mock-challenged animals (<xref rid="F10" ref-type="fig">Fig. 10F</xref>). At day 12 postinfection, Tohama 1-infected rats showed a significant increase, nearly double anti-<italic toggle="yes">B. pertussis</italic> IgG antibody titers compared to rats infected with D420. AUC analysis revealed a significant increase in anti-<italic toggle="yes">B. pertussis</italic> IgM antibodies from rats infected with D420 compared to Tohama 1-infected rats (see Fig. S12A). However, no difference was observed in the AUC values of the anti-<italic toggle="yes">B. pertussis</italic> IgG antibody response over the total course of infection between the bacterial challenge groups (see Fig. S12B). It is also important to note that we also did not see a significant increase in the generation of antibodies titers to PT, ACT, PRN, and FHA in <italic toggle="yes">B. pertussis</italic>-infected rats compared to mock-challenged animals (<xref rid="F10" ref-type="fig">Fig. 10B, E,</xref> and <xref rid="F10" ref-type="fig">G</xref> to <xref rid="F10" ref-type="fig">J</xref>). We also note that IgA antibodies were not detected to either whole bacteria or PT in the lung and nasal cavity at days 1 and 9 postchallenge (data not shown).</p>
                <fig position="float" id="F10">
                  <label>FIG 10</label>
                  <caption>
                    <p>Measurement of serum antibody titers over the course of <named-content content-type="genus-species">B. pertussis</named-content> infection. ELISA was used to compare serological responses from rats intranasal challenge with <named-content content-type="genus-species">B. pertussis</named-content>. Total IgM and IgG serum antibody titers were measured from challenged rats against whole <named-content content-type="genus-species">B. pertussis</named-content> bacterium (A and F), FHA (B and G), PRN (C and H), PT (D and I), and ACT (E and J). The dotted line represents the average serum titer for mock-challenged rats. <italic toggle="yes">P</italic> values were determined by two-way ANOVA corrected with Bonferroni comparison test (*, <italic toggle="yes">P &lt; </italic>0.05; **<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.001; ***<italic toggle="yes">*</italic>, <italic toggle="yes">P &lt; </italic>0.0001 [compared between infection groups]). For comparison to the mock-challenged control group, one-way ANOVA was used, followed by a Tukey comparison test (##, <italic toggle="yes">P</italic> &lt; 0.01; ###, <italic toggle="yes">P</italic> &lt; 0.001).</p>
                  </caption>
                  <graphic xlink:href="iai.00304-21-f010" position="float"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="discussion" id="s3">
              <title>DISCUSSION</title>
              <p>To date, humans are the only known reservoir for <italic toggle="yes">B. pertussis</italic>, making the development of a suitable animal model challenging. Multiple models have been studied to recapitulate similar disease symptoms seen in humans, as well as provide insight into the pathogenesis of <italic toggle="yes">B. pertussis</italic>. We set out to reinvestigate the rat model of pertussis that was originally introduced in 1938 (<xref rid="B6" ref-type="bibr">6</xref>). In our study, we have confirmed that intranasal administration of <italic toggle="yes">B. pertussis</italic> led to bacterial colonization of the upper and lower respiratory tracts (<xref rid="F7" ref-type="fig">Fig. 7</xref>). Through intranasal instillation, bacteria were able to infect the nasal cavity, trachea, and lungs postchallenge. This is important since infants with pertussis experience pneumonia more frequently than do adolescents and adults (<xref rid="B35" ref-type="bibr">35</xref>). Mouse models of pertussis also rely on depositing large numbers of bacteria into the lung to establish infection (<xref rid="B2" ref-type="bibr">2</xref>). Here, our data show that through intranasal infection, we can establish an infection of both the upper and lower respiratory tracts, resembling the infection seen in adolescents and adults with pertussis (<xref rid="B52" ref-type="bibr">52</xref>, <xref rid="B53" ref-type="bibr">53</xref>).</p>
              <p>Previous reports have shown <italic toggle="yes">B. pertussis</italic> infection of rats induced paroxysmal coughs, and these coughs were counted by analog audio recordings (<xref rid="B7" ref-type="bibr">7</xref>). Utilizing WBP, we are able to precisely and digitally count coughs and measure the respiratory capacity for the first time with rats infected with <italic toggle="yes">B. pertussis</italic> (<xref rid="F2" ref-type="fig">Fig. 2</xref> and <xref rid="F3" ref-type="fig">3</xref>). Here, coughs induced from infection appeared at days 1 to 2 postchallenge, with the number of coughs gradually increasing with peak cough occurring at day 8 postchallenge. Rats challenged with intrabronchial instillation of <italic toggle="yes">B. pertussis</italic> noted similar peak cough counts approximately 10 days postchallenge (<xref rid="B54" ref-type="bibr">54</xref>). This is also one of the first studies utilizing WBP to count coughs in rats with bacterial infection. We did observe some infected rats that did not overtly cough. This reflects the frequency of coughs in adolescents and adults (<xref rid="B55" ref-type="bibr">55</xref>). Previous studies using baboons also show that <italic toggle="yes">B. pertussis</italic> infection elicits severe coughs lasting over 2 weeks postchallenge, with peak coughs per hour occurring at day 4 postchallenge (<xref rid="B26" ref-type="bibr">26</xref>). It is also important to note that at peak coughing, the bacterial burden was low, which was also observed in previous research on <italic toggle="yes">B. pertussis</italic>-infected rats (<xref rid="B7" ref-type="bibr">7</xref>). The data suggest that other factors could be playing a role in cough production despite the bacterial infection being resolved. Given that <italic toggle="yes">B. pertussis</italic>-infected rats coughed, we also investigated transmission of <italic toggle="yes">B. pertussis</italic> from infected 7-week-old rats (actively coughing) cohoused with more susceptible 3-week-old rats, and we have observed no evidence of transmission via negative qPCR (IS<italic toggle="yes">481</italic>) analysis of swabs from the nasal cavity and no active coughing in the naive 3-week-old rats. We also performed a challenge study with <italic toggle="yes">B. bronchiseptica</italic> strain KM22 in 7-week-old Sprague-Dawley rats, and challenged rats coughed more violently and earlier after bacterial challenge compared to <italic toggle="yes">B. pertussis</italic>-infected rats. <italic toggle="yes">B. bronchiseptica</italic>-infected rats coughed the most when the bacterial loads in the respiratory tract were at their highest, which could potentially lead to transmission of the bacterium. TLR4-deficient rats could be investigated to evaluate transmission of <italic toggle="yes">B. pertussis</italic> (<xref rid="B56" ref-type="bibr">56</xref>). We also observed that the increased bronchial restriction coincides with the increased coughs during days 6 to 11 postchallenge (<xref rid="F3" ref-type="fig">Fig. 3</xref>). The decreased lung capacity and increase in cough could be further associated with an increase of chronic inflammation in the lung (<xref rid="F4" ref-type="fig">Fig. 4</xref>). Our data suggest that the coughing rat model of pertussis can be used to potentially evaluate the mechanism of cough, which still requires further investigation.</p>
              <p>Initial studies characterizing the serum antibody response to rats infected with <italic toggle="yes">B. pertussis</italic> noted an increase antibody response to endotoxin correlated with the small number of cultivable organisms in the lung following intrabronchial challenge (<xref rid="B7" ref-type="bibr">7</xref>). Hall et al. demonstrated that rats infected with <italic toggle="yes">B. pertussis</italic> become seropositive in response to whole-cell <italic toggle="yes">B. pertussis</italic> lysate, FHA, and PT by 28 days after intrabronchial challenge (<xref rid="B8" ref-type="bibr">8</xref>). Anti-FHA antibody titers were not detected until day 16 postchallenge, whereas anti-PT antibody titers were not detected until day 28 postchallenge (<xref rid="B23" ref-type="bibr">23</xref>). In our study, we characterized the antibody response following intranasal challenge of <italic toggle="yes">B. pertussis</italic> over the whole infection timeline. Using <italic toggle="yes">B. pertussis</italic>-coated ELISA plates, we detected anti-<italic toggle="yes">B. pertussis</italic> IgG antibody titers in rats infected with <italic toggle="yes">B. pertussis</italic> at day 9 postchallenge, with a significant increase compared to mock challenge observed at day 12 (<xref rid="F10" ref-type="fig">Fig. 10</xref>). We also measured a significant increase in anti-<italic toggle="yes">B. pertussis</italic> IgM antibody titers in rats infected with D420 compared to the mock-challenged and Tohama 1-infected animals (<xref rid="F10" ref-type="fig">Fig. 10</xref>). One potential hypothesis that could explain this observation is the genetic differences between the two strains as D420 harbors the <italic toggle="yes">ptxP3</italic> allele, leading to an increase in PT production (<xref rid="B25" ref-type="bibr">25</xref>). PT has been shown to suppress <italic toggle="yes">B. pertussis</italic> antibody responses in serum and limit the expression of antigen-presenting receptors (<xref rid="B57" ref-type="bibr">57</xref><xref rid="B58" ref-type="bibr">–</xref><xref rid="B60" ref-type="bibr">60</xref>).</p>
              <p>With the increased interest in developing new pertussis vaccines, it is imperative for the development of animal models to evaluate the pathogenic potential of current emerging strains, as well as to identify any potential differences in disease burden between genetically divergent strains. Sato and Sato first used <italic toggle="yes">B. pertussis</italic> strain Tohama 1 in the development of the acellular pertussis vaccine, and Tohama 1 is still being used in pertussis research today, notably due to its genetic malleability (<xref rid="B61" ref-type="bibr">61</xref>). D420 has been instrumental in the development of the baboon model and has also been used to study vaccine efficacy in regard to transmission in the baboon model (<xref rid="B29" ref-type="bibr">29</xref>). We hypothesize that the observed differences could be due to the increased amount of PT through the <italic toggle="yes">ptxP3</italic> allele of D420 (<xref rid="B25" ref-type="bibr">25</xref>). Strains, such as D420, harboring the <italic toggle="yes">ptxP3</italic> allele lead to an increase in virulence, PT production, and prevalence (<xref rid="B62" ref-type="bibr">62</xref>, <xref rid="B63" ref-type="bibr">63</xref>). A previous study utilizing the intranasal mouse model has shown an increase in bacterial colonization with <italic toggle="yes">ptxP3</italic> strains (<xref rid="B64" ref-type="bibr">64</xref>). Parton et al. illustrated that infection with a PT-deficient strain was unable to induce cough (<xref rid="B9" ref-type="bibr">9</xref>). It is possible that there are other factors beyond PT that can account for the observed virulence differences between Tohama I and D420. In the rat model, unlike the mouse, we also did not measure any significant increases in IL-17 and IL-6 in the lung and serum after challenge. IL-17 and IL-6 are increased following <italic toggle="yes">B. pertussis</italic> infection in mice and baboons (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B48" ref-type="bibr">48</xref>, <xref rid="B65" ref-type="bibr">65</xref>). Further investigation is needed to explain the observed differences. One potential approach to evaluate differences between strains is the use of a neonatal rat model of pertussis. Studying <italic toggle="yes">B. pertussis</italic> in neonates may be useful in distinguishing subtle differences between strains. Hornibrook et al. demonstrated that <italic toggle="yes">B. pertussis</italic>-infected young 3-week-old rats demonstrated 65% mortality, while 7-week-old rats do not succumb to infection with a similar dose (<xref rid="B6" ref-type="bibr">6</xref>).</p>
              <p>In summary, we have demonstrated that the rat model of pertussis can be used as a tool to further study <italic toggle="yes">B. pertussis</italic> pathogenesis and recapitulate some of the similar symptoms of pertussis as seen in humans. Pertussis is often described as a “100-day cough” because adolescents and adults experience an extended duration of coughing (<xref rid="B66" ref-type="bibr">66</xref>). Coughing episodes in infants with pertussis can lead to vomiting, choking, gagging, and apneic episodes that can lead to seizures (<xref rid="B67" ref-type="bibr">67</xref>). Mice have not been used to evaluate coughing manifestation in pertussis until recently, and baboons are expensive and limited to specialized facilities (<xref rid="B68" ref-type="bibr">68</xref>). Use of the coughing rat model of pertussis provides feasibility through low husbandry costs, the ready availability of animals, and its ease of use as a model. The immunological tools available in murine research is vast, but as basic research continue to evolve, so, too, will the resources and immunological tools available for rats. Recently, flow cytometry markers have been developed to study innate immune cells and adaptive immune cells, such as B and T cells (<xref rid="B47" ref-type="bibr">47</xref>). In other studies, we have used ELISpot assays to investigate antigen-specific immune populations as well. The increasing availability of antibodies has also allowed investigation of systemic and mucosal serological responses. Future studies utilizing the coughing rat model of pertussis will capitalize on the growing immunological toolbox in regard to vaccination against pertussis.</p>
              <p>In this study, we carefully compared two established strains that have been used in the pertussis field, Tohama 1 and D420. In future studies, we aim to evaluate whole-cell and acellular vaccine-mediated immunity against D420. Armed with this model, we can further our understanding of pathogenesis, host response during pertussis, genetic divergence between strains, and vaccine-mediated immunity.</p>
            </sec>
            <sec sec-type="materials|methods" id="s4">
              <title>MATERIALS AND METHODS</title>
              <sec id="s4-1">
                <title><italic toggle="yes">Bordetella pertussis</italic> strains and growth conditions.</title>
                <p><italic toggle="yes">B. pertussis</italic> strain Tohama 1 was graciously provided by Peter Sebo (Czech Academy of Sciences), and strain D420 was acquired from the CDC Pertussis Lab provided by Maria L. Tondella and Michael Weigand. <italic toggle="yes">B. pertussis</italic> strain Tohama 1 and D420 were cultured on Bordet-Gengou (BG) agar (Remel, catalog no. R45232) that was supplemented with 15% defibrinated sheep blood (Hemostat Laboratories, catalog no. DSB500) (<xref rid="B69" ref-type="bibr">69</xref>). Bacteria were cultured on BG plates for 48 h at 36°C. <italic toggle="yes">B. pertussis</italic> was transferred from BG plates with polyester swabs (Puritan, catalog no. 22-029-574) and transferred into 20 ml of Stainer-Scholte liquid media (SSM) in new, 125-ml flasks (Thermo Fisher Scientific, catalog no. FB50000125) (<xref rid="B70" ref-type="bibr">70</xref>). The liquid cultures were grown for 24 h at 36°C inside a shaking incubator at 180 rpm.</p>
              </sec>
              <sec id="s4-2">
                <title>Intranasal challenge with <italic toggle="yes">B. pertussis</italic>.</title>
                <p>Seven-week-old ∼170-g female Sprague-Dawley rats (Charles River, catalog no. 001CD) were used for challenge. <italic toggle="yes">B. pertussis</italic> was grown as described above. The rats were then anesthetized with ketamine and xylazine (50 to 100 and 5 to 10 mg/kg, respectively) and challenged with 10<sup>8</sup> CFU (100 μl intranasally), administering two 50-μl doses, one in each nostril (<xref rid="F1" ref-type="fig">Fig. 1</xref>). The body weight of each rat was recorded both before challenge and immediately after euthanasia. Rats were euthanized at days 1, 3, 6, 9, and 12 after bacterial challenge. Mock-challenge animals (no bacteria) were administered 100 μl of sterile endotoxin-free PBS (Thermo Fisher Scientific, catalog no. TMS012A) intranasally. Upon euthanasia, blood was collected via cardiac puncture and transferred into EDTA (BD, catalog no. 365974) and serum separation (BD, catalog no. 026897) tubes. Blood collected in the EDTA tube was used for flow cytometric analysis, while blood collected in the serum separation tubes were used to isolate the serum via centrifugation (15,000 × <italic toggle="yes">g</italic> for 3 min) and used for serological and cytokine analysis. Lungs and tracheas were excised and homogenized to determine the bacterial burden. Upon removal, the wet weight of the lungs was recorded. Lungs were then collected in gentleMACS C tubes (Miltenyi Biotec) and homogenized using a gentleMACS dissociator (catalog no. 130-095-927). The trachea was homogenized using a Polytron homogenizer. To determine the bacterial burden in the nares, 2 ml of sterile 1× PBS was flushed through the nares, and then samples were collected for plating. Serial dilutions of the homogenates and nasal collections were plated on BG plates supplemented with ceftibuten (Sigma-Aldrich, catalog no. SML0037) at 10 μg/ml to decrease the growth of normal rat respiratory tract flora.</p>
              </sec>
              <sec id="s4-3">
                <title>Analysis of coughing and bronchiole restriction using whole-body plethysmography.</title>
                <p>To quantify respiratory function during infection, we utilized a Buxco FinePointe Whole Body Plethysmograph instrument (WBP; DSI). FinePointe software was used to collect, analyze, and report the breathing data. Every day postchallenge for 12 consecutive days at 5:00 p.m., the rats were placed inside designated chambers to acclimate for 5 min. We chose this time not only due to rats being nocturnal but also because at this time the animals were most awake and active, as confirmed by video camera (data not shown). After acclimation, each rat’s respiratory profile was recorded for 15 min. Each chamber is fitted with a transducer that measured the changes in box flow and airflow of the subject. The chambers were also fitted with a screen pneumotach that allowed airflow in and out of the chamber that can be recorded. Coughs were counted during the designated 15 min, and the enhanced pause (PenH) was calculated to signify bronchiole restriction. Coughs were counted based on large box flow changes of the subject and changes in both humidity and temperature of the air flowing in and out of the subject with classical cough-like waveforms. Cough detection algorithm was applied using a patented fuzzy logic criteria to determine whether the event was a cough (<xref rid="B71" ref-type="bibr">71</xref>). When analyzing the number of coughs, each cough in a multicough event was counted individually.</p>
              </sec>
              <sec id="s4-4">
                <title>Histological assessment of the lung and NALT.</title>
                <p>Upon euthanasia, the rat skull was excised, and the mandible was removed. The skulls were fixed in 10% formalin (Fisher Scientific, catalog no. SF98-4) for 48 h at 26°C. After fixation, the formalin was removed, and the skulls were frozen at −80°C until decalcification. Skulls were decalcified using Richard-Allan Scientific decalcifying solution (Thermo Scientific, catalog no. 8340-1) at room temperature for 24 to 48 h and then embedded in paraffin. Samples were sectioned and stained with H&amp;E. A BioTek Lionheart Fx was used to scan and image the NALT. ImageJ was used to trace and measure the area of both the left and the right NALT using the images from the Lionheart Fx. The left lobe of the lung was excised and fixed in 10% formalin 48 h at 26°C. The left lobe was then embedded in paraffin and stained with H&amp;E by the WVU Pathology Department. H&amp;E-stained sections were used to characterize and score acute and chronic inflammation of the lung. All scorings were done by a board-certified pathologist (iHisto). Individual scores were based on a standard qualitative scoring criterion: 0, none; 1, minimal (rare); 2, mild (slight); 3, moderate; 4, marked; and 5, severe. Chronic inflammation was characterized by mononuclear infiltrates of the parenchyma, blood vessels, and airway. Acute inflammation scores were assigned due to the presence of neutrophils in the parenchyma, blood vessels, and airway. All examination and scoring were performed blindly since no knowledge of the treatment groups was known.</p>
              </sec>
              <sec id="s4-5">
                <title>Imaging of <italic toggle="yes">B. pertussis</italic> in the lung and nasal cavity.</title>
                <p>Detection of <italic toggle="yes">B. pertussis</italic> in the nasal cavity and lung was quantified via IF and confocal imaging. The left lobe of the lung and nasal cavity were preserved and sectioned as described above. Sectioned samples underwent deparaffination and rehydration using xylene and ethanol (70 to 100%). Antigen retrieval was performed by incubating samples in citrate buffer at 98°C for 20 min. Samples were blocked using 5% bovine serum albumin (Fisher Scientific, catalog no. 159008) for 1 h and primarily labeled utilizing a polyclonal rabbit FHA antibody (a gift from Erik Hewlett) diluted in 1× PBS. Secondary labeling occurred utilizing an anti-rabbit IgG conjugated with Texas Red (Fisher Scientific, catalog no. T2767) diluted in 1× PBS. Samples were then covered in mounting media (Prolong Gold Antifade reagent with [4′,6′-diamidino-2-phenylindole], catalog no. 8961). Samples were imaged using a Nikon A1R confocal microscope. Images were analyzed on DAPI channel and at wavelength 650 nm for Texas Red acquisition. Images were acquired using a 100× oil immersion lens (100×/1.40 Nikon Plan APO). To identify any potential differences in IF between the two strains, all IF images were deidentified, and the microcolonies were manually counted blindly by four volunteers with two to three fields of view used per sample.</p>
              </sec>
              <sec id="s4-6">
                <title>Flow cytometry analysis of phagocytes.</title>
                <p>Neutrophil recruitment in the blood was evaluated by flow cytometry. Blood samples upon collection were then lysed with PharmLyse buffer (BD Biosciences, catalog no. 555899) for 20 min at room temperature, with slight vortexing throughout. The remaining cells were resuspended in RPMI–10% fetal bovine serum (FBS) to neutralize the lysis buffer, centrifuged five times at 1,000 × <italic toggle="yes">g</italic>, and then washed with RPMI–10% FBS again. Blood was then resuspended in 1% FBS–PBS–5 mM EDTA. Samples were next blocked with anti-CD32 (BD Pharmingen, catalog no. 550270) antibody for 30 min at 4°C. After incubation, the cells were stained with the appropriate antibody markers: CD45-Alexa Fluor 700 (BioLegend, catalog no. 202218), CD161-APC (BioLegend, catalog no. 205606), CD45R-PE-Cy7 (eBioscience, catalog no. 25-0460-82), His48-FITC (eBioscience, catalog no. 11-0570-82), CD43-PE (BioLegend, catalog no. 202812), and CD3-VioGreen (Miltenyi Biotec, catalog no. 130-119-125) (<xref rid="B47" ref-type="bibr">47</xref>). After the addition of antibodies, the cells were incubated 1 h at 4°C in the dark. To prepare the lung samples for flow cytometry, the lung homogenate was pushed through a 70-μm-pore-size cell strainer (BioDesign Cell MicroSives, catalog no. N70R), creating a single-cell suspension. The suspension was then centrifuged at 1,000 × <italic toggle="yes">g</italic> for 5 min. After removal of the supernatant, the pellet was resuspended in PharmLyse buffer, and the cells were incubated at 37°C for 2 min. After incubation, the cells were centrifuged at 1,000 × <italic toggle="yes">g</italic> for 5 min, and the supernatant was removed, blocked, and labeled with antibody, as described above. The lung and blood samples were centrifuged at 1,000 × <italic toggle="yes">g</italic> for 5 min, and the pellets were resuspended in 0.4% paraformaldehyde and stored overnight at 4°C. Samples were washed with 1× PBS and resuspended in 1× PBS for analysis. Cell samples were analyzed on a LSR Fortessa, and samples were gated and analyzed using FlowJo v10.</p>
              </sec>
              <sec id="s4-7">
                <title>Lung and serum cytokine and chemokine analysis.</title>
                <p>Lung homogenate samples were centrifuged at 19,000 × <italic toggle="yes">g</italic> for 4 min, and the supernatant was removed and stored at −80°C. Quantitative analysis of cytokines in the serum and lung homogenate was performed using a ProcartaPlex multiplex immunoassay kit (Cytokine &amp; Chemokine 22-Plex Rat ProcartaPlex panel, catalog no. EPX220-30122-901) according to the manufacturer’s instructions.</p>
              </sec>
              <sec id="s4-8">
                <title>Serological analysis.</title>
                <p>Antibody titers of infected rats were measured by ELISA. <named-content content-type="genus-species">B. pertussis</named-content>-specific ELISA plates were coated with 50 μl of 10<sup>8</sup>
<named-content content-type="genus-species">B. pertussis</named-content> grown, as mentioned above for infection. To measure antibody titers to FHA (Enzo ALX-630-123-0100), PRN (GSK), PT (List Biological Laboratories, catalog no. 180), and ACT (a gift from Erik Hewlett), we coated plates with 50 μl of each antigen at 1 μg/ml. Once coated, the plates were incubated overnight at 4°C. The plates were washed with 1× PBS-Tween 20 and then blocked with 5% skim milk for 2 h at 37°C. The plates were washed again, and the sera from the challenge studies were serially diluted down the ELISA plate, followed by incubation for 2 h at 37°C. After incubation, the plates were washed and coated with 100 μl of secondary goat anti-rat IgG (Southern Biotech, catalog no. 3030-04) and IgM (Southern Biotech, catalog no. 3020-04) antibody at a dilution of 1:2,000 in PBS–5% milk. Once coated, the plate was incubated for 1 h at 37°C. The plates were washed again with PBS-Tween 20, and 100 μl of <italic toggle="yes">p</italic>-nitrophenyl phosphate substate (Thermo Scientific, catalog no. 37620), prepared according to the manufacturer’s instructions, was added. The plate was then developed for 30 min at room temperature to determine the titers of IgG and IgM. A BioTek Synergy H1 microplate reader was used to measure the colorimetric signal of the ELISA plate at <italic toggle="yes">A</italic><sub>450</sub>. Positive antibody titers were determined as any values that were higher than the baseline. The baseline was set as double the average value of the blank; no serum added to these wells.</p>
              </sec>
              <sec id="s4-9">
                <title>Generating Nightingale Rose plots in Python.</title>
                <p>Data from individual mice were averaged in Microsoft Excel and log transformed. Values were formatted in Excel to be compatible with Python. Data were imported from .csv files using the pandas package and plotted using the “Barpolar” representation feature in the plotly.graph_objects module. Samples with a titer of &lt;50 were assigned a value of 0.</p>
              </sec>
              <sec id="s4-10">
                <title>Statistical analysis.</title>
                <p>All data were analyzed using GraphPad Prism 7. The minimum number of biological replicates for the challenge studies was 4. For statistical comparisons between multiple groups over the entire course of the infection, a two-way analysis of variance (ANOVA) was used. One-way ANOVA was used for comparisons between groups for each individual day with Tukey’s <italic toggle="yes">post hoc</italic> test. Unpaired Student <italic toggle="yes">t</italic> tests were used for AUC analysis. Specific follow-up statistical tests are annotated in the figure legends.</p>
              </sec>
              <sec id="s4-11">
                <title>Ethics statement.</title>
                <p>All studies were performed in accordance with West Virginia University Institutional Animal Care and Use Committee approved protocol 1811019148.6.</p>
              </sec>
              <sec id="s4-12">
                <title>Data availability.</title>
                <p>Data requests for figures provided can be addressed to the corresponding author.</p>
              </sec>
            </sec>
          </body>
          <back>
            <ack>
              <title>ACKNOWLEDGMENTS</title>
              <p>The preliminary work on this project was in part supported by the Vaccine Development Center at WVU-HSC through research challenge grant HEPC.dsr.18.6 from the Division of Science and Research, WV Higher Education Policy Commission. The project was also supported by NIH R01AI137155 (F.H.D.) and CDC Contract (Broad Agency Announcement) 75D301-19-R-67835 (F.H.D.). Flow cytometry experiments were performed in the West Virginia University Flow Cytometry Core Facility, which is supported the National Institutes of Health equipment grant S10OD016165 and an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grants P30GM103488 (CoBRE) and P20GM103434 (INBRE).</p>
              <p>J.M.H., D.T.B., and J.K. performed bacterial challenge. J.M.H., S.M.K., and J.K. monitored rat coughing and respiratory function by whole-body plethysmography. All authors participated in the animal experiments. J.M.H. and E.S.-K. contributed to flow cytometry panel design and analysis. J.M.H. and T.Y.W. prepared and ran flow cytometry samples. M.A.W. and M.A.D. performed cytokine analysis. J.M.H. analyzed H&amp;E histology slides. J.M.H. and G.J.B. performed and analyzed immunohistochemistry. J.M.H. performed ELISAs. J.M.H., M.B., and F.H.D. contributed to experimental design. J.M.H. wrote manuscript with critical revisions from all authors.</p>
              <p>We thank Kathleen Brundage (WVU Flow Cytometry and Single Cell Core Facility) for assisting in flow cytometry and equipment instruction. We thank Amanda Ammer (Microscope Imaging Facility) for support in imaging the IF slides. We also thank James Coad, Jacqueline Karakiozis, and Brice Hickey (Pathology/Histology Core Facility) for the preparation of lung and nasal cavity for IF and performing H&amp;E on the lung and nasal cavity.</p>
            </ack>
            <fn-group>
              <fn fn-type="supplementary-material">
                <p>Supplemental material is available online only.</p>
                <p>
                  <supplementary-material id="SuF1" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1128/IAI.00304-21.1</object-id>
                    <label>Supplemental file 1</label>
                    <caption>
                      <p>Supplemental material. Download <inline-supplementary-material id="SF1" xlink:href="iai.00304-21-s0001.pdf" content-type="local-data">iai.00304-21-s0001.pdf, PDF file, 1.0 MB</inline-supplementary-material></p>
                    </caption>
                  </supplementary-material>
                  <supplementary-material id="SuF2" position="float" content-type="local-data">
                    <object-id pub-id-type="doi">10.1128/IAI.00304-21.2</object-id>
                    <label>Supplemental file 2</label>
                    <caption>
                      <p>Supplemental material. Download <inline-supplementary-material id="SF2" xlink:href="iai.00304-21-s0002.xlsx" content-type="local-data">iai.00304-21-s0002.xlsx, XLSX file, 0.06 MB</inline-supplementary-material></p>
                    </caption>
                  </supplementary-material>
                </p>
              </fn>
            </fn-group>
            <ref-list>
              <title>REFERENCES</title>
              <ref id="B1">
                <label>1</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mattoo</surname><given-names>S</given-names></string-name>, <string-name><surname>Cherry</surname><given-names>JD</given-names></string-name></person-group>. <year>2005</year>. <article-title>Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to <italic toggle="yes">Bordetella pertussis</italic> and other <italic toggle="yes">Bordetella</italic> subspecies</article-title>. <source>Clin Microbiol Rev</source><volume>18</volume>:<fpage>326</fpage>–<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.18.2.326-382.2005</pub-id>.<pub-id pub-id-type="pmid">15831828</pub-id></mixed-citation>
              </ref>
              <ref id="B2">
                <label>2</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Melvin</surname><given-names>JA</given-names></string-name>, <string-name><surname>Scheller</surname><given-names>EV</given-names></string-name>, <string-name><surname>Miller</surname><given-names>JF</given-names></string-name>, <string-name><surname>Cotter</surname><given-names>PA</given-names></string-name></person-group>. <year>2014</year>. <article-title><italic toggle="yes">Bordetella pertussis</italic> pathogenesis: current and future challenges</article-title>. <source>Nat Rev Microbiol</source><volume>12</volume>:<fpage>274</fpage>–<lpage>288</lpage>. <pub-id pub-id-type="doi">10.1038/nrmicro3235</pub-id>.<pub-id pub-id-type="pmid">24608338</pub-id></mixed-citation>
              </ref>
              <ref id="B3">
                <label>3</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weigand</surname><given-names>MR</given-names></string-name>, <string-name><surname>Peng</surname><given-names>Y</given-names></string-name>, <string-name><surname>Loparev</surname><given-names>V</given-names></string-name>, <string-name><surname>Batra</surname><given-names>D</given-names></string-name>, <string-name><surname>Bowden</surname><given-names>KE</given-names></string-name>, <string-name><surname>Burroughs</surname><given-names>M</given-names></string-name>, <string-name><surname>Cassiday</surname><given-names>PK</given-names></string-name>, <string-name><surname>Davis</surname><given-names>JK</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>T</given-names></string-name>, <string-name><surname>Juieng</surname><given-names>P</given-names></string-name>, <string-name><surname>Knipe</surname><given-names>K</given-names></string-name>, <string-name><surname>Mathis</surname><given-names>MH</given-names></string-name>, <string-name><surname>Pruitt</surname><given-names>AM</given-names></string-name>, <string-name><surname>Rowe</surname><given-names>L</given-names></string-name>, <string-name><surname>Sheth</surname><given-names>M</given-names></string-name>, <string-name><surname>Tondella</surname><given-names>ML</given-names></string-name>, <string-name><surname>Williams</surname><given-names>MM</given-names></string-name></person-group>. <year>2017</year>. <article-title>The history of <italic toggle="yes">Bordetella pertussis</italic> genome evolution includes structural rearrangement</article-title>. <source>J Bacteriol</source><volume>199</volume>:<elocation-id>e00806-16</elocation-id>. <pub-id pub-id-type="doi">10.1128/JB.00806-16</pub-id>.<pub-id pub-id-type="pmid">28167525</pub-id></mixed-citation>
              </ref>
              <ref id="B4">
                <label>4</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elahi</surname><given-names>S</given-names></string-name>, <string-name><surname>Holmstrom</surname><given-names>J</given-names></string-name>, <string-name><surname>Gerdts</surname><given-names>V</given-names></string-name></person-group>. <year>2007</year>. <article-title>The benefits of using diverse animal models for studying pertussis</article-title>. <source>Trends Microbiol</source><volume>15</volume>:<fpage>462</fpage>–<lpage>468</lpage>. <pub-id pub-id-type="doi">10.1016/j.tim.2007.09.003</pub-id>.<pub-id pub-id-type="pmid">17920273</pub-id></mixed-citation>
              </ref>
              <ref id="B5">
                <label>5</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cherry</surname><given-names>JD</given-names></string-name></person-group>. <year>2015</year>. <article-title>The history of pertussis (whooping cough), 1906–2015: facts, myths, and misconceptions</article-title>. <source>Curr Epidemiol Rep</source><volume>2</volume>:<fpage>120</fpage>–<lpage>130</lpage>. <pub-id pub-id-type="doi">10.1007/s40471-015-0041-9</pub-id>.</mixed-citation>
              </ref>
              <ref id="B6">
                <label>6</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hornibrook</surname><given-names>JW</given-names></string-name>, <string-name><surname>Ashburn</surname><given-names>LL</given-names></string-name></person-group>. <year>1939</year>. <article-title>A study of experimental pertussis in the young rat</article-title>. <source>Public Heal Rep</source><volume>54</volume>:<fpage>439</fpage>. <pub-id pub-id-type="doi">10.2307/4582826</pub-id>.</mixed-citation>
              </ref>
              <ref id="B7">
                <label>7</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Woods</surname><given-names>DE</given-names></string-name>, <string-name><surname>Franklin</surname><given-names>R</given-names></string-name>, <string-name><surname>Cryz</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Ganss</surname><given-names>M</given-names></string-name>, <string-name><surname>Peppler</surname><given-names>M</given-names></string-name>, <string-name><surname>Ewanowich</surname><given-names>C</given-names></string-name></person-group>. <year>1989</year>. <article-title>Development of a rat model for respiratory infection with <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Infect Immun</source><volume>57</volume>:<fpage>1018</fpage>–<lpage>1024</lpage>. <pub-id pub-id-type="doi">10.1128/iai.57.4.1018-1024.1989</pub-id>.<pub-id pub-id-type="pmid">2538394</pub-id></mixed-citation>
              </ref>
              <ref id="B8">
                <label>8</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Parton</surname><given-names>R</given-names></string-name>, <string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name></person-group>. <year>1994</year>. <article-title>Cough production, leukocytosis, and serology of rats infected intrabronchially with <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>J Med Microbiol</source><volume>40</volume>:<fpage>205</fpage>–<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1099/00222615-40-3-205</pub-id>.<pub-id pub-id-type="pmid">8114072</pub-id></mixed-citation>
              </ref>
              <ref id="B9">
                <label>9</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parton</surname><given-names>R</given-names></string-name>, <string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name></person-group>. <year>1994</year>. <article-title>Responses to <italic toggle="yes">Bordetella pertussis</italic> mutant strains and to vaccination in the coughing rat model of pertussis</article-title>. <source>J Med Microbiol</source><volume>40</volume>:<fpage>307</fpage>–<lpage>312</lpage>. <pub-id pub-id-type="doi">10.1099/00222615-40-5-307</pub-id>.<pub-id pub-id-type="pmid">8176718</pub-id></mixed-citation>
              </ref>
              <ref id="B10">
                <label>10</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Parton</surname><given-names>R</given-names></string-name>, <string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name></person-group>. <year>1997</year>. <article-title>Differences in coughing and other responses to intrabronchial infection with <italic toggle="yes">Bordetella pertussis</italic> among strains of rats</article-title>. <source>Infect Immun</source><volume>65</volume>:<fpage>4711</fpage>–<lpage>4717</lpage>. <pub-id pub-id-type="doi">10.1128/iai.65.11.4711-4717.1997</pub-id>.<pub-id pub-id-type="pmid">9353055</pub-id></mixed-citation>
              </ref>
              <ref id="B11">
                <label>11</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Parton</surname><given-names>R</given-names></string-name>, <string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name></person-group>. <year>1998</year>. <article-title>Responses to acellular pertussis vaccines and component antigens in a coughing rat model of pertussis</article-title>. <source>Vaccine</source><volume>16</volume>:<fpage>1595</fpage>–<lpage>1603</lpage>. <pub-id pub-id-type="doi">10.1016/S0264-410X(98)80001-7</pub-id>.<pub-id pub-id-type="pmid">9713934</pub-id></mixed-citation>
              </ref>
              <ref id="B12">
                <label>12</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Nakamura</surname><given-names>K</given-names></string-name>, <string-name><surname>Shinoda</surname><given-names>N</given-names></string-name>, <string-name><surname>Hiramatsu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ohnishi</surname><given-names>S</given-names></string-name>, <string-name><surname>Kamitani</surname><given-names>S</given-names></string-name>, <string-name><surname>Ogura</surname><given-names>Y</given-names></string-name>, <string-name><surname>Hayashi</surname><given-names>T</given-names></string-name>, <string-name><surname>Horiguchi</surname><given-names>Y</given-names></string-name></person-group>. <year>2019</year>. <article-title>BspR/BtrA, an anti-σ factor, regulates the ability of <italic toggle="yes">Bordetella bronchiseptica</italic> to cause cough in rats</article-title>. <source>mSphere</source><volume>4</volume>:<elocation-id>e00093-19</elocation-id>. <pub-id pub-id-type="doi">10.1128/mSphere.00093-19</pub-id>.<pub-id pub-id-type="pmid">31019000</pub-id></mixed-citation>
              </ref>
              <ref id="B13">
                <label>13</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Libster</surname><given-names>R</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>KM</given-names></string-name></person-group>. <year>2012</year>. <article-title>Re-emergence of pertussis: what are the solutions?</article-title><source>Expert Rev Vaccines</source><volume>11</volume>:<fpage>1331</fpage>–<lpage>1346</lpage>. <pub-id pub-id-type="doi">10.1586/erv.12.118</pub-id>.<pub-id pub-id-type="pmid">23249233</pub-id></mixed-citation>
              </ref>
              <ref id="B14">
                <label>14</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hill</surname><given-names>HA</given-names></string-name>, <string-name><surname>Elam-Evans</surname><given-names>LD</given-names></string-name>, <string-name><surname>Yankey</surname><given-names>D</given-names></string-name>, <string-name><surname>Singleton</surname><given-names>JA</given-names></string-name>, <string-name><surname>Dietz</surname><given-names>V</given-names></string-name></person-group>. <year>2016</year>. <article-title>Vaccination coverage among children aged 19–35 months—United States, 2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source><volume>65</volume>:<fpage>1065</fpage>–<lpage>1071</lpage>. <pub-id pub-id-type="doi">10.15585/mmwr.mm6539a4</pub-id>.<pub-id pub-id-type="pmid">27711036</pub-id></mixed-citation>
              </ref>
              <ref id="B15">
                <label>15</label>
                <mixed-citation publication-type="journal"><collab>CDC</collab>. <year>2011</year>. <article-title>National, state, and local area vaccination coverage among children aged 19–35 months—United States</article-title>. <source>MMWR</source><volume>61</volume><issue>(35)</issue>:<fpage>689</fpage>–<lpage>696</lpage>. <ext-link xlink:href="https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm" ext-link-type="uri">https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6135a1.htm</ext-link>.</mixed-citation>
              </ref>
              <ref id="B16">
                <label>16</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klein</surname><given-names>NP</given-names></string-name>, <string-name><surname>Bartlett</surname><given-names>J</given-names></string-name>, <string-name><surname>Fireman</surname><given-names>B</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>R</given-names></string-name></person-group>. <year>2016</year>. <article-title>Waning Tdap effectiveness in adolescents</article-title>. <source>Pediatrics</source><volume>137</volume>:<elocation-id>e20153326</elocation-id>. <pub-id pub-id-type="doi">10.1542/peds.2015-3326</pub-id>.<pub-id pub-id-type="pmid">26908667</pub-id></mixed-citation>
              </ref>
              <ref id="B17">
                <label>17</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klein</surname><given-names>NP</given-names></string-name>, <string-name><surname>Bartlett</surname><given-names>J</given-names></string-name>, <string-name><surname>Rowhani-Rahbar</surname><given-names>A</given-names></string-name>, <string-name><surname>Fireman</surname><given-names>B</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>R</given-names></string-name></person-group>. <year>2012</year>. <article-title>Waning protection after fifth dose of acellular pertussis vaccine in children</article-title>. <source>N Engl J Med</source><volume>367</volume>:<fpage>1012</fpage>–<lpage>1019</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1200850</pub-id>.<pub-id pub-id-type="pmid">22970945</pub-id></mixed-citation>
              </ref>
              <ref id="B18">
                <label>18</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Klein</surname><given-names>NP</given-names></string-name>, <string-name><surname>Bartlett</surname><given-names>J</given-names></string-name>, <string-name><surname>Fireman</surname><given-names>B</given-names></string-name>, <string-name><surname>Rowhani-Rahbar</surname><given-names>A</given-names></string-name>, <string-name><surname>Baxter</surname><given-names>R</given-names></string-name></person-group>. <year>2013</year>. <article-title>Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers</article-title>. <source>Pediatrics</source><volume>131</volume>:<fpage>e1716</fpage>–<lpage>e1722</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2012-3836</pub-id>.<pub-id pub-id-type="pmid">23690518</pub-id></mixed-citation>
              </ref>
              <ref id="B19">
                <label>19</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheridan</surname><given-names>SL</given-names></string-name>, <string-name><surname>Frith</surname><given-names>K</given-names></string-name>, <string-name><surname>Snelling</surname><given-names>TL</given-names></string-name>, <string-name><surname>Grimwood</surname><given-names>K</given-names></string-name>, <string-name><surname>McIntyre</surname><given-names>PB</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>SB</given-names></string-name></person-group>. <year>2014</year>. <article-title>Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology</article-title>. <source>Expert Rev Vaccines</source><volume>13</volume>:<fpage>1081</fpage>–<lpage>1106</lpage>. <pub-id pub-id-type="doi">10.1586/14760584.2014.944167</pub-id>.<pub-id pub-id-type="pmid">25093268</pub-id></mixed-citation>
              </ref>
              <ref id="B20">
                <label>20</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sheridan</surname><given-names>SL</given-names></string-name>, <string-name><surname>Ware</surname><given-names>RS</given-names></string-name>, <string-name><surname>Grimwood</surname><given-names>K</given-names></string-name>, <string-name><surname>Lambert</surname><given-names>SB</given-names></string-name></person-group>. <year>2012</year>. <article-title>Number and order of whole cell pertussis vaccines in infancy and disease protection</article-title>. <source>JAMA</source><volume>308</volume>:<fpage>454</fpage>. <pub-id pub-id-type="doi">10.1001/jama.2012.6364</pub-id>.</mixed-citation>
              </ref>
              <ref id="B21">
                <label>21</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tartof</surname><given-names>SY</given-names></string-name>, <string-name><surname>Lewis</surname><given-names>M</given-names></string-name>, <string-name><surname>Kenyon</surname><given-names>C</given-names></string-name>, <string-name><surname>White</surname><given-names>K</given-names></string-name>, <string-name><surname>Osborn</surname><given-names>A</given-names></string-name>, <string-name><surname>Liko</surname><given-names>J</given-names></string-name>, <string-name><surname>Zell</surname><given-names>E</given-names></string-name>, <string-name><surname>Martin</surname><given-names>S</given-names></string-name>, <string-name><surname>Messonnier</surname><given-names>NE</given-names></string-name>, <string-name><surname>Clark</surname><given-names>TA</given-names></string-name>, <string-name><surname>Skoff</surname><given-names>TH</given-names></string-name></person-group>. <year>2013</year>. <article-title>Waning immunity to pertussis following 5 doses of DTaP</article-title>. <source>Pediatrics</source><volume>131</volume>:<fpage>e1047</fpage>–<lpage>e1052</lpage>. <pub-id pub-id-type="doi">10.1542/peds.2012-1928</pub-id>.<pub-id pub-id-type="pmid">23478868</pub-id></mixed-citation>
              </ref>
              <ref id="B22">
                <label>22</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Williams</surname><given-names>MM</given-names></string-name>, <string-name><surname>Sen</surname><given-names>KA</given-names></string-name>, <string-name><surname>Weigand</surname><given-names>MR</given-names></string-name>, <string-name><surname>Skoff</surname><given-names>TH</given-names></string-name>, <string-name><surname>Cunningham</surname><given-names>VA</given-names></string-name>, <string-name><surname>Halse</surname><given-names>TA</given-names></string-name>, <string-name><surname>Tondella</surname><given-names>ML</given-names></string-name></person-group>. <year>2016</year>. <article-title><italic toggle="yes">Bordetella pertussis</italic> strain lacking pertactin and pertussis toxin</article-title>. <source>Emerg Infect Dis</source><volume>22</volume>:<fpage>319</fpage>–<lpage>322</lpage>. <pub-id pub-id-type="doi">10.3201/eid2202.151332</pub-id>.<pub-id pub-id-type="pmid">26812174</pub-id></mixed-citation>
              </ref>
              <ref id="B23">
                <label>23</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Parton</surname><given-names>R</given-names></string-name>, <string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name></person-group>. <year>1999</year>. <article-title>Time-course of infection and responses in a coughing rat model of pertussis</article-title>. <source>J Med Microbiol</source><volume>48</volume>:<fpage>95</fpage>–<lpage>98</lpage>. <pub-id pub-id-type="doi">10.1099/00222615-48-1-95</pub-id>.<pub-id pub-id-type="pmid">9920131</pub-id></mixed-citation>
              </ref>
              <ref id="B24">
                <label>24</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parkhill</surname><given-names>J</given-names></string-name>, <string-name><surname>Sebaihia</surname><given-names>M</given-names></string-name>, <string-name><surname>Preston</surname><given-names>A</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>LD</given-names></string-name>, <string-name><surname>Thomson</surname><given-names>N</given-names></string-name>, <string-name><surname>Harris</surname><given-names>DE</given-names></string-name>, <string-name><surname>Holden</surname><given-names>MTG</given-names></string-name>, <string-name><surname>Churcher</surname><given-names>CM</given-names></string-name>, <string-name><surname>Bentley</surname><given-names>SD</given-names></string-name>, <string-name><surname>Mungall</surname><given-names>KL</given-names></string-name>, <string-name><surname>Cerdeño-Tárraga</surname><given-names>AM</given-names></string-name>, <string-name><surname>Temple</surname><given-names>L</given-names></string-name>, <string-name><surname>James</surname><given-names>K</given-names></string-name>, <string-name><surname>Harris</surname><given-names>B</given-names></string-name>, <string-name><surname>Quail</surname><given-names>MA</given-names></string-name>, <string-name><surname>Achtman</surname><given-names>M</given-names></string-name>, <string-name><surname>Atkin</surname><given-names>R</given-names></string-name>, <string-name><surname>Baker</surname><given-names>S</given-names></string-name>, <string-name><surname>Basham</surname><given-names>D</given-names></string-name>, <string-name><surname>Bason</surname><given-names>N</given-names></string-name>, <string-name><surname>Cherevach</surname><given-names>I</given-names></string-name>, <string-name><surname>Chillingworth</surname><given-names>T</given-names></string-name>, <string-name><surname>Collins</surname><given-names>M</given-names></string-name></person-group>, <etal>et al</etal>. <year>2003</year>. <article-title>Comparative analysis of the genome sequences of <italic toggle="yes">Bordetella pertussis</italic>, <italic toggle="yes">Bordetella parapertussis</italic>, and <italic toggle="yes">Bordetella bronchiseptica</italic></article-title>. <source>Nat Genet</source><volume>35</volume>:<fpage>32</fpage>–<lpage>40</lpage>. <pub-id pub-id-type="doi">10.1038/ng1227</pub-id>.<pub-id pub-id-type="pmid">12910271</pub-id></mixed-citation>
              </ref>
              <ref id="B25">
                <label>25</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boinett</surname><given-names>CJ</given-names></string-name>, <string-name><surname>Harris</surname><given-names>SR</given-names></string-name>, <string-name><surname>Langridge</surname><given-names>GC</given-names></string-name>, <string-name><surname>Trainor</surname><given-names>EA</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name>, <string-name><surname>Parkhill</surname><given-names>J</given-names></string-name></person-group>. <year>2015</year>. <article-title>Complete genome sequence of <italic toggle="yes">Bordetella pertussis</italic> D420</article-title>. <source>Genome Announc</source><volume>3</volume>. <pub-id pub-id-type="doi">10.1128/genomeA.00842-15</pub-id>.</mixed-citation>
              </ref>
              <ref id="B26">
                <label>26</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warfel</surname><given-names>JM</given-names></string-name>, <string-name><surname>Beren</surname><given-names>J</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>VK</given-names></string-name>, <string-name><surname>Lee</surname><given-names>G</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name></person-group>. <year>2012</year>. <article-title>Nonhuman primate model of pertussis</article-title>. <source>Infect Immun</source><volume>80</volume>:<fpage>1530</fpage>–<lpage>1536</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.06310-11</pub-id>.<pub-id pub-id-type="pmid">22252879</pub-id></mixed-citation>
              </ref>
              <ref id="B27">
                <label>27</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warfel</surname><given-names>JM</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name></person-group>. <year>2014</year>. <article-title>The baboon model of pertussis: effective use and lessons for pertussis vaccines</article-title>. <source>Expert Rev Vaccines</source><volume>13</volume>:<fpage>1241</fpage>–<lpage>1252</lpage>. <pub-id pub-id-type="doi">10.1586/14760584.2014.946016</pub-id>.<pub-id pub-id-type="pmid">25182980</pub-id></mixed-citation>
              </ref>
              <ref id="B28">
                <label>28</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Pinto</surname><given-names>MV</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name></person-group>. <year>2017</year>. <article-title>Pertussis disease and transmission and host responses: insights from the baboon model of pertussis</article-title>. <source>J Infect</source><volume>74</volume>:<fpage>S114</fpage>–<lpage>S119</lpage>. <pub-id pub-id-type="doi">10.1016/S0163-4453(17)30201-3</pub-id>.<pub-id pub-id-type="pmid">28646950</pub-id></mixed-citation>
              </ref>
              <ref id="B29">
                <label>29</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warfel</surname><given-names>JM</given-names></string-name>, <string-name><surname>Zimmerman</surname><given-names>LI</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name></person-group>. <year>2014</year>. <article-title>Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model</article-title>. <source>Proc Natl Acad Sci USA</source><volume>111</volume>:<fpage>787</fpage>–<lpage>792</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.1314688110</pub-id>.<pub-id pub-id-type="pmid">24277828</pub-id></mixed-citation>
              </ref>
              <ref id="B30">
                <label>30</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Warfel</surname><given-names>JM</given-names></string-name>, <string-name><surname>Merkel</surname><given-names>TJ</given-names></string-name></person-group>. <year>2013</year>. <article-title><italic toggle="yes">Bordetella pertussis</italic> infection induces a mucosal IL-17 response and long-lived Th17 and Th1 immune memory cells in nonhuman primates</article-title>. <source>Mucosal Immunol</source><volume>6</volume>:<fpage>787</fpage>–<lpage>796</lpage>. <pub-id pub-id-type="doi">10.1038/mi.2012.117</pub-id>.<pub-id pub-id-type="pmid">23187316</pub-id></mixed-citation>
              </ref>
              <ref id="B31">
                <label>31</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kasuga</surname><given-names>T</given-names></string-name>, <string-name><surname>Nakase</surname><given-names>Y</given-names></string-name>, <string-name><surname>Ukishima</surname><given-names>K</given-names></string-name>, <string-name><surname>Takatsu</surname><given-names>K</given-names></string-name></person-group>. <year>1954</year>. <article-title>Studies on <italic toggle="yes">Haemophilus pertussis.</italic> V. Relation between the phase of bacilli and the progress of the whooping-cough</article-title>. <source>Kitasato Arch Exp Med</source><volume>27</volume>:<fpage>57</fpage>–<lpage>62</lpage>.<pub-id pub-id-type="pmid">13296323</pub-id></mixed-citation>
              </ref>
              <ref id="B32">
                <label>32</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Caro</surname><given-names>V</given-names></string-name>, <string-name><surname>Bouchez</surname><given-names>V</given-names></string-name>, <string-name><surname>Guiso</surname><given-names>N</given-names></string-name></person-group>. <year>2008</year>. <article-title>Is the sequenced <italic toggle="yes">Bordetella pertussis</italic> strain Tohama I representative of the species?</article-title><source>J Clin Microbiol</source><volume>46</volume>:<fpage>2125</fpage>–<lpage>2128</lpage>. <pub-id pub-id-type="doi">10.1128/JCM.02484-07</pub-id>.<pub-id pub-id-type="pmid">18385436</pub-id></mixed-citation>
              </ref>
              <ref id="B33">
                <label>33</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sato</surname><given-names>H</given-names></string-name>, <string-name><surname>Sato</surname><given-names>Y</given-names></string-name></person-group>. <year>1985</year>. <article-title>Protective antigens of <italic toggle="yes">Bordetella pertussis</italic> mouse-protection test against intracerebral and aerosol challenge of <italic toggle="yes">B. pertussis</italic></article-title>. <source>Dev Biol Stand</source><volume>61</volume>:<fpage>461</fpage>–<lpage>467</lpage>.<pub-id pub-id-type="pmid">2872127</pub-id></mixed-citation>
              </ref>
              <ref id="B34">
                <label>34</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barbier</surname><given-names>M</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>DT</given-names></string-name>, <string-name><surname>Sen-Kilic</surname><given-names>E</given-names></string-name>, <string-name><surname>Bonnin</surname><given-names>C</given-names></string-name>, <string-name><surname>Pinheiro</surname><given-names>T</given-names></string-name>, <string-name><surname>Hoffman</surname><given-names>C</given-names></string-name>, <string-name><surname>Gray</surname><given-names>M</given-names></string-name>, <string-name><surname>Hewlett</surname><given-names>E</given-names></string-name>, <string-name><surname>Damron</surname><given-names>FH</given-names></string-name></person-group>. <year>2017</year>. <article-title>Modulation of pertussis and adenylate cyclase toxins by sigma factor RpoE in <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>Infect Immun</source><volume>85</volume>. <pub-id pub-id-type="doi">10.1128/IAI.00565-16</pub-id>.</mixed-citation>
              </ref>
              <ref id="B35">
                <label>35</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Paddock</surname><given-names>CD</given-names></string-name>, <string-name><surname>Sanden</surname><given-names>GN</given-names></string-name>, <string-name><surname>Cherry</surname><given-names>JD</given-names></string-name>, <string-name><surname>Gal</surname><given-names>AA</given-names></string-name>, <string-name><surname>Langston</surname><given-names>C</given-names></string-name>, <string-name><surname>Tatti</surname><given-names>KM</given-names></string-name>, <string-name><surname>Wu</surname><given-names>K</given-names></string-name>, <string-name><surname>Goldsmith</surname><given-names>CS</given-names></string-name>, <string-name><surname>Greer</surname><given-names>PW</given-names></string-name>, <string-name><surname>Montague</surname><given-names>JL</given-names></string-name>, <string-name><surname>Eliason</surname><given-names>MT</given-names></string-name>, <string-name><surname>Holman</surname><given-names>RC</given-names></string-name>, <string-name><surname>Guarner</surname><given-names>J</given-names></string-name>, <string-name><surname>Shieh</surname><given-names>W</given-names></string-name>, <string-name><surname>Zaki</surname><given-names>SR</given-names></string-name></person-group>. <year>2008</year>. <article-title>Pathology and pathogenesis of fatal <italic toggle="yes">Bordetella pertussis</italic> infection in infants</article-title>. <source>Clin Infect Dis</source><volume>47</volume>:<fpage>328</fpage>–<lpage>338</lpage>. <pub-id pub-id-type="doi">10.1086/589753</pub-id>.<pub-id pub-id-type="pmid">18558873</pub-id></mixed-citation>
              </ref>
              <ref id="B36">
                <label>36</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Verheijden</surname><given-names>KAT</given-names></string-name>, <string-name><surname>Henricks</surname><given-names>PAJ</given-names></string-name>, <string-name><surname>Redegeld</surname><given-names>FA</given-names></string-name>, <string-name><surname>Garssen</surname><given-names>J</given-names></string-name>, <string-name><surname>Folkerts</surname><given-names>G</given-names></string-name></person-group>. <year>2014</year>. <article-title>Measurement of airway function using invasive and noninvasive methods in mild and severe models for allergic airway inflammation in mice</article-title>. <source>Front Pharmacol</source><volume>5</volume>:<fpage>190</fpage>.<pub-id pub-id-type="pmid">25161620</pub-id></mixed-citation>
              </ref>
              <ref id="B37">
                <label>37</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leist</surname><given-names>SR</given-names></string-name>, <string-name><surname>Dinnon</surname><given-names>KH</given-names></string-name>, <string-name><surname>Schäfer</surname><given-names>A</given-names></string-name>, <string-name><surname>Tse</surname><given-names>LV</given-names></string-name>, <string-name><surname>Okuda</surname><given-names>K</given-names></string-name>, <string-name><surname>Hou</surname><given-names>YJ</given-names></string-name>, <string-name><surname>West</surname><given-names>A</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>CE</given-names></string-name>, <string-name><surname>Sanders</surname><given-names>W</given-names></string-name>, <string-name><surname>Fritch</surname><given-names>EJ</given-names></string-name>, <string-name><surname>Gully</surname><given-names>KL</given-names></string-name>, <string-name><surname>Scobey</surname><given-names>T</given-names></string-name>, <string-name><surname>Brown</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Sheahan</surname><given-names>TP</given-names></string-name>, <string-name><surname>Moorman</surname><given-names>NJ</given-names></string-name>, <string-name><surname>Boucher</surname><given-names>RC</given-names></string-name>, <string-name><surname>Gralinski</surname><given-names>LE</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>SA</given-names></string-name>, <string-name><surname>Baric</surname><given-names>RS</given-names></string-name></person-group>. <year>2020</year>. <article-title>A mouse-adapted SARS-CoV-2 induces acute lung injury and mortality in standard laboratory mice</article-title>. <source>Cell</source><volume>183</volume>:<fpage>1070</fpage>–<lpage>1085</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2020.09.050</pub-id>.<pub-id pub-id-type="pmid">33031744</pub-id></mixed-citation>
              </ref>
              <ref id="B38">
                <label>38</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Dinnon</surname><given-names>KH</given-names></string-name>, <string-name><surname>Leist</surname><given-names>SR</given-names></string-name>, <string-name><surname>Schäfer</surname><given-names>A</given-names></string-name>, <string-name><surname>Edwards</surname><given-names>CE</given-names></string-name>, <string-name><surname>Martinez</surname><given-names>DR</given-names></string-name>, <string-name><surname>Montgomery</surname><given-names>SA</given-names></string-name>, <string-name><surname>West</surname><given-names>A</given-names></string-name>, <string-name><surname>Yount</surname><given-names>BL</given-names></string-name>, <string-name><surname>Hou</surname><given-names>YJ</given-names></string-name>, <string-name><surname>Adams</surname><given-names>LE</given-names></string-name>, <string-name><surname>Gully</surname><given-names>KL</given-names></string-name>, <string-name><surname>Brown</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Huang</surname><given-names>E</given-names></string-name>, <string-name><surname>Bryant</surname><given-names>MD</given-names></string-name>, <string-name><surname>Choong</surname><given-names>IC</given-names></string-name>, <string-name><surname>Glenn</surname><given-names>JS</given-names></string-name>, <string-name><surname>Gralinski</surname><given-names>LE</given-names></string-name>, <string-name><surname>Sheahan</surname><given-names>TP</given-names></string-name>, <string-name><surname>Baric</surname><given-names>RS</given-names></string-name></person-group>. <year>2020</year>. <article-title>A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures</article-title>. <source>Nature</source><volume>586</volume>:<fpage>560</fpage>–<lpage>566</lpage>. <pub-id pub-id-type="doi">10.1038/s41586-020-2708-8</pub-id>.<pub-id pub-id-type="pmid">32854108</pub-id></mixed-citation>
              </ref>
              <ref id="B39">
                <label>39</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Takaki</surname><given-names>H</given-names></string-name>, <string-name><surname>Ichimiya</surname><given-names>S</given-names></string-name>, <string-name><surname>Matsumoto</surname><given-names>M</given-names></string-name>, <string-name><surname>Seya</surname><given-names>T</given-names></string-name></person-group>. <year>2018</year>. <article-title>Mucosal immune response in nasal-associated lymphoid tissue upon intranasal administration by adjuvants</article-title>. <source>J Innate Immun</source><volume>10</volume>:<fpage>515</fpage>–<lpage>521</lpage>. <pub-id pub-id-type="doi">10.1159/000489405</pub-id>.<pub-id pub-id-type="pmid">29860261</pub-id></mixed-citation>
              </ref>
              <ref id="B40">
                <label>40</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Asanuma</surname><given-names>H</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>AH</given-names></string-name>, <string-name><surname>Iwasaki</surname><given-names>T</given-names></string-name>, <string-name><surname>Sato</surname><given-names>Y</given-names></string-name>, <string-name><surname>Inaba</surname><given-names>Y</given-names></string-name>, <string-name><surname>Aizawa</surname><given-names>C</given-names></string-name>, <string-name><surname>Kurata</surname><given-names>T</given-names></string-name>, <string-name><surname>Tamura</surname><given-names>S</given-names></string-name></person-group>. <year>1997</year>. <article-title>Isolation and characterization of mouse nasal-associated lymphoid tissue</article-title>. <source>J Immunol Methods</source><volume>202</volume>:<fpage>123</fpage>–<lpage>131</lpage>. <pub-id pub-id-type="doi">10.1016/S0022-1759(96)00243-8</pub-id>.<pub-id pub-id-type="pmid">9107301</pub-id></mixed-citation>
              </ref>
              <ref id="B41">
                <label>41</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Debertin</surname><given-names>AS</given-names></string-name>, <string-name><surname>Tschernig</surname><given-names>T</given-names></string-name>, <string-name><surname>Tönjes</surname><given-names>H</given-names></string-name>, <string-name><surname>Kleemann</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Tröger</surname><given-names>HD</given-names></string-name>, <string-name><surname>Pabst</surname><given-names>R</given-names></string-name></person-group>. <year>2003</year>. <article-title>Nasal-associated lymphoid tissue (NALT): frequency and localization in young children</article-title>. <source>Clin Exp Immunol</source><volume>134</volume>:<fpage>503</fpage>–<lpage>507</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2249.2003.02311.x</pub-id>.<pub-id pub-id-type="pmid">14632758</pub-id></mixed-citation>
              </ref>
              <ref id="B42">
                <label>42</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hirano</surname><given-names>T</given-names></string-name>, <string-name><surname>Kodama</surname><given-names>S</given-names></string-name>, <string-name><surname>Moriyama</surname><given-names>M</given-names></string-name>, <string-name><surname>Kawano</surname><given-names>T</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>M</given-names></string-name></person-group>. <year>2009</year>. <article-title>The role of Toll-like receptor 4 in eliciting acquired immune responses against nontypeable <italic toggle="yes">Haemophilus influenzae</italic> following intranasal immunization with outer membrane protein</article-title>. <source>Int J Pediatr Otorhinolaryngol</source><volume>73</volume>:<fpage>1657</fpage>–<lpage>1665</lpage>. <pub-id pub-id-type="doi">10.1016/j.ijporl.2009.08.015</pub-id>.<pub-id pub-id-type="pmid">19765832</pub-id></mixed-citation>
              </ref>
              <ref id="B43">
                <label>43</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Petukhova</surname><given-names>G</given-names></string-name>, <string-name><surname>Naikhin</surname><given-names>A</given-names></string-name>, <string-name><surname>Chirkova</surname><given-names>T</given-names></string-name>, <string-name><surname>Donina</surname><given-names>S</given-names></string-name>, <string-name><surname>Korenkov</surname><given-names>D</given-names></string-name>, <string-name><surname>Rudenko</surname><given-names>L</given-names></string-name></person-group>. <year>2009</year>. <article-title>Comparative studies of local antibody and cellular immune responses to influenza infection and vaccination with live attenuated reassortant influenza vaccine (LAIV) utilizing a mouse nasal-associated lymphoid tissue (NALT) separation method</article-title>. <source>Vaccine</source><volume>27</volume>:<fpage>2580</fpage>–<lpage>2587</lpage>. <pub-id pub-id-type="doi">10.1016/j.vaccine.2009.02.035</pub-id>.<pub-id pub-id-type="pmid">19428864</pub-id></mixed-citation>
              </ref>
              <ref id="B44">
                <label>44</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zuercher</surname><given-names>AW</given-names></string-name>, <string-name><surname>Coffin</surname><given-names>SE</given-names></string-name>, <string-name><surname>Thurnheer</surname><given-names>MC</given-names></string-name>, <string-name><surname>Fundova</surname><given-names>P</given-names></string-name>, <string-name><surname>Cebra</surname><given-names>JJ</given-names></string-name></person-group>. <year>2002</year>. <article-title>Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses</article-title>. <source>J Immunol</source><volume>168</volume>:<fpage>1796</fpage>–<lpage>1803</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.168.4.1796</pub-id>.<pub-id pub-id-type="pmid">11823512</pub-id></mixed-citation>
              </ref>
              <ref id="B45">
                <label>45</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boehm</surname><given-names>DT</given-names></string-name>, <string-name><surname>Hall</surname><given-names>JM</given-names></string-name>, <string-name><surname>Wong</surname><given-names>TY</given-names></string-name>, <string-name><surname>DiVenere</surname><given-names>A</given-names></string-name>, <string-name><surname>Sen-Kilic</surname><given-names>E</given-names></string-name>, <string-name><surname>Bevere</surname><given-names>JR</given-names></string-name>, <string-name><surname>Bradford</surname><given-names>SD</given-names></string-name>, <string-name><surname>Blackwood</surname><given-names>CB</given-names></string-name>, <string-name><surname>Elkins</surname><given-names>C</given-names></string-name>, <string-name><surname>DeRoos</surname><given-names>KA</given-names></string-name>, <string-name><surname>Gray</surname><given-names>MC</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>CG</given-names></string-name>, <string-name><surname>Varney</surname><given-names>ME</given-names></string-name>, <string-name><surname>Maynard</surname><given-names>JA</given-names></string-name>, <string-name><surname>Hewlett</surname><given-names>EL</given-names></string-name>, <string-name><surname>Barbier</surname><given-names>M</given-names></string-name>, <string-name><surname>Damron</surname><given-names>FH</given-names></string-name></person-group>. <year>2018</year>. <article-title>Evaluation of adenylate cyclase toxoid antigen in acellular pertussis vaccines using a <italic toggle="yes">Bordetella pertussis</italic> challenge model in mice</article-title>. <source>Infect Immun</source><volume>86</volume>. <pub-id pub-id-type="doi">10.1128/IAI.00857-17</pub-id>.</mixed-citation>
              </ref>
              <ref id="B46">
                <label>46</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sawal</surname><given-names>M</given-names></string-name>, <string-name><surname>Cohen</surname><given-names>M</given-names></string-name>, <string-name><surname>Irazuzta</surname><given-names>JE</given-names></string-name>, <string-name><surname>Kumar</surname><given-names>R</given-names></string-name>, <string-name><surname>Kirton</surname><given-names>C</given-names></string-name>, <string-name><surname>Brundler</surname><given-names>M-A</given-names></string-name>, <string-name><surname>Evans</surname><given-names>CA</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>JA</given-names></string-name>, <string-name><surname>Raffeeq</surname><given-names>P</given-names></string-name>, <string-name><surname>Azaz</surname><given-names>A</given-names></string-name>, <string-name><surname>Rotta</surname><given-names>AT</given-names></string-name>, <string-name><surname>Vora</surname><given-names>A</given-names></string-name>, <string-name><surname>Vohra</surname><given-names>A</given-names></string-name>, <string-name><surname>Abboud</surname><given-names>P</given-names></string-name>, <string-name><surname>Mirkin</surname><given-names>LD</given-names></string-name>, <string-name><surname>Cooper</surname><given-names>M</given-names></string-name>, <string-name><surname>Dishop</surname><given-names>MK</given-names></string-name>, <string-name><surname>Graf</surname><given-names>JM</given-names></string-name>, <string-name><surname>Petros</surname><given-names>A</given-names></string-name>, <string-name><surname>Klonin</surname><given-names>H</given-names></string-name></person-group>. <year>2009</year>. <article-title>Fulminant pertussis: a multi-center study with new insights into the clinico-pathological mechanisms</article-title>. <source>Pediatr Pulmonol</source><volume>44</volume>:<fpage>970</fpage>–<lpage>980</lpage>. <pub-id pub-id-type="doi">10.1002/ppul.21082</pub-id>.<pub-id pub-id-type="pmid">19725100</pub-id></mixed-citation>
              </ref>
              <ref id="B47">
                <label>47</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Barnett-Vanes</surname><given-names>A</given-names></string-name>, <string-name><surname>Sharrock</surname><given-names>A</given-names></string-name>, <string-name><surname>Birrell</surname><given-names>MA</given-names></string-name>, <string-name><surname>Rankin</surname><given-names>S</given-names></string-name></person-group>. <year>2016</year><article-title>A single 9-colour flow cytometric method to characterize major leukocyte populations in the rat: validation in a model of LPS-Induced pulmonary inflammation</article-title>. PLoS One <volume>11</volume>:<elocation-id>e0142520</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0142520</pub-id>.</mixed-citation>
              </ref>
              <ref id="B48">
                <label>48</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Boehm</surname><given-names>DT</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>MA</given-names></string-name>, <string-name><surname>Hall</surname><given-names>JM</given-names></string-name>, <string-name><surname>Wong</surname><given-names>TY</given-names></string-name>, <string-name><surname>Sen-Kilic</surname><given-names>E</given-names></string-name>, <string-name><surname>Basinger</surname><given-names>HD</given-names></string-name>, <string-name><surname>Dziadowicz</surname><given-names>SA</given-names></string-name>, <string-name><surname>Gutierrez</surname><given-names>M</given-names></string-name>, <string-name><surname>de la</surname><given-names>P</given-names></string-name>, <string-name><surname>Blackwood</surname><given-names>CB</given-names></string-name>, <string-name><surname>Bradford</surname><given-names>SD</given-names></string-name>, <string-name><surname>Begley</surname><given-names>KA</given-names></string-name>, <string-name><surname>Witt</surname><given-names>WT</given-names></string-name>, <string-name><surname>Varney</surname><given-names>ME</given-names></string-name>, <string-name><surname>Barbier</surname><given-names>M</given-names></string-name>, <string-name><surname>Damron</surname><given-names>FH</given-names></string-name></person-group>. <year>2019</year>. <article-title>Intranasal acellular pertussis vaccine provides mucosal immunity and protects mice from <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>NPJ Vaccines</source><volume>4</volume>:<fpage>1</fpage>–<lpage>12</lpage>. <pub-id pub-id-type="doi">10.1038/s41541-019-0136-2</pub-id>.<pub-id pub-id-type="pmid">30622742</pub-id></mixed-citation>
              </ref>
              <ref id="B49">
                <label>49</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zhang</surname><given-names>X</given-names></string-name>, <string-name><surname>Goel</surname><given-names>T</given-names></string-name>, <string-name><surname>Goodfield</surname><given-names>LL</given-names></string-name>, <string-name><surname>Muse</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Harvill</surname><given-names>ET</given-names></string-name></person-group>. <year>2011</year>. <article-title>Decreased leukocyte accumulation and delayed <italic toggle="yes">Bordetella pertussis</italic> clearance in IL-6<sup>–/–</sup> mice</article-title>. <source>J Immunol</source><volume>186</volume>:<fpage>4895</fpage>–<lpage>4904</lpage>. <pub-id pub-id-type="doi">10.4049/jimmunol.1000594</pub-id>.<pub-id pub-id-type="pmid">21398615</pub-id></mixed-citation>
              </ref>
              <ref id="B50">
                <label>50</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wolf</surname><given-names>MA</given-names></string-name>, <string-name><surname>Boehm</surname><given-names>DT</given-names></string-name>, <string-name><surname>DeJong</surname><given-names>MA</given-names></string-name>, <string-name><surname>Wong</surname><given-names>TY</given-names></string-name>, <string-name><surname>Sen-Kilic</surname><given-names>E</given-names></string-name>, <string-name><surname>Hall</surname><given-names>JM</given-names></string-name>, <string-name><surname>Blackwood</surname><given-names>CB</given-names></string-name>, <string-name><surname>Weaver</surname><given-names>KL</given-names></string-name>, <string-name><surname>Kelly</surname><given-names>CO</given-names></string-name>, <string-name><surname>Kisamore</surname><given-names>CA</given-names></string-name>, <string-name><surname>Bitzer</surname><given-names>GJ</given-names></string-name>, <string-name><surname>Bevere</surname><given-names>JR</given-names></string-name>, <string-name><surname>Barbier</surname><given-names>M</given-names></string-name>, <string-name><surname>Damron</surname><given-names>FH</given-names></string-name></person-group>. <year>2021</year>. <article-title>Intranasal immunization with acellular pertussis vaccines results in long-term immunity to <italic toggle="yes">Bordetella pertussis</italic> in mice</article-title>. <source>Infect Immun</source><volume>89</volume>. <pub-id pub-id-type="doi">10.1128/IAI.00607-20</pub-id>.</mixed-citation>
              </ref>
              <ref id="B51">
                <label>51</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andreasen</surname><given-names>C</given-names></string-name>, <string-name><surname>Carbonetti</surname><given-names>NH</given-names></string-name></person-group>. <year>2009</year>. <article-title>Role of neutrophils in response to <italic toggle="yes">Bordetella pertussis</italic> infection in mice</article-title>. <source>Infect Immun</source><pub-id pub-id-type="doi">10.1128/IAI.01150-08</pub-id>.</mixed-citation>
              </ref>
              <ref id="B52">
                <label>52</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Solans</surname><given-names>L</given-names></string-name>, <string-name><surname>Locht</surname><given-names>C</given-names></string-name></person-group>. <year>2018</year>. <article-title>The role of mucosal immunity in pertussis</article-title>. <source>Front Immunol</source><volume>9</volume>:<fpage>3068</fpage>. <pub-id pub-id-type="doi">10.3389/fimmu.2018.03068</pub-id>.<pub-id pub-id-type="pmid">30692990</pub-id></mixed-citation>
              </ref>
              <ref id="B53">
                <label>53</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>de Graaf</surname><given-names>H</given-names></string-name>, <string-name><surname>Ibrahim</surname><given-names>M</given-names></string-name>, <string-name><surname>Hill</surname><given-names>AR</given-names></string-name>, <string-name><surname>Gbesemete</surname><given-names>D</given-names></string-name>, <string-name><surname>Vaughan</surname><given-names>AT</given-names></string-name>, <string-name><surname>Gorringe</surname><given-names>A</given-names></string-name>, <string-name><surname>Preston</surname><given-names>A</given-names></string-name>, <string-name><surname>Buisman</surname><given-names>AM</given-names></string-name>, <string-name><surname>Faust</surname><given-names>SN</given-names></string-name>, <string-name><surname>Kester</surname><given-names>KE</given-names></string-name>, <string-name><surname>Berbers</surname><given-names>GAM</given-names></string-name>, <string-name><surname>Diavatopoulos</surname><given-names>DA</given-names></string-name>, <string-name><surname>Read</surname><given-names>RC</given-names></string-name></person-group>. <year>2020</year>. <article-title>Controlled human infection with <italic toggle="yes">Bordetella pertussis</italic> induces asymptomatic, immunizing colonization</article-title>. <source>Clin Infect Dis</source><volume>71</volume>:<fpage>403</fpage>–<lpage>411</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciz840</pub-id>.<pub-id pub-id-type="pmid">31562530</pub-id></mixed-citation>
              </ref>
              <ref id="B54">
                <label>54</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wardlaw</surname><given-names>AC</given-names></string-name>, <string-name><surname>Hall</surname><given-names>E</given-names></string-name>, <string-name><surname>Parton</surname><given-names>R</given-names></string-name></person-group>. <year>1993</year>. <article-title>Coughing rat model of pertussis</article-title>. <source>Biologicals</source><volume>21</volume>:<fpage>27</fpage>–<lpage>29</lpage>. <pub-id pub-id-type="doi">10.1006/biol.1993.1024</pub-id>.</mixed-citation>
              </ref>
              <ref id="B55">
                <label>55</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kilgore</surname><given-names>PE</given-names></string-name>, <string-name><surname>Salim</surname><given-names>AM</given-names></string-name>, <string-name><surname>Zervos</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Schmitt</surname><given-names>H-J</given-names></string-name></person-group>. <year>2016</year>. <article-title>Pertussis: microbiology, disease, treatment, and prevention</article-title>. <source>Clin Microbiol Rev</source><volume>29</volume>:<fpage>449</fpage>–<lpage>486</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00083-15</pub-id>.<pub-id pub-id-type="pmid">27029594</pub-id></mixed-citation>
              </ref>
              <ref id="B56">
                <label>56</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Rolin</surname><given-names>O</given-names></string-name>, <string-name><surname>Smallridge</surname><given-names>W</given-names></string-name>, <string-name><surname>Henry</surname><given-names>M</given-names></string-name>, <string-name><surname>Goodfield</surname><given-names>L</given-names></string-name>, <string-name><surname>Place</surname><given-names>D</given-names></string-name>, <string-name><surname>Harvill</surname><given-names>ET</given-names></string-name></person-group>. <year>2014</year>. <article-title>Toll-like receptor 4 limits transmission of <italic toggle="yes">Bordetella bronchiseptica</italic></article-title>. <source>PLoS One</source><volume>9</volume>:<elocation-id>e85229</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0085229</pub-id>.<pub-id pub-id-type="pmid">24497924</pub-id></mixed-citation>
              </ref>
              <ref id="B57">
                <label>57</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Connelly</surname><given-names>CE</given-names></string-name>, <string-name><surname>Sun</surname><given-names>Y</given-names></string-name>, <string-name><surname>Carbonetti</surname><given-names>NH</given-names></string-name></person-group>. <year>2012</year>. <article-title>Pertussis toxin exacerbates and prolongs airway inflammatory responses during <italic toggle="yes">Bordetella pertussis</italic> infection</article-title>. <source>Infect Immun</source><volume>80</volume>:<fpage>4317</fpage>–<lpage>4332</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.00808-12</pub-id>.<pub-id pub-id-type="pmid">23027529</pub-id></mixed-citation>
              </ref>
              <ref id="B58">
                <label>58</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carbonetti</surname><given-names>NH</given-names></string-name>, <string-name><surname>Artamonova</surname><given-names>GV</given-names></string-name>, <string-name><surname>Andreasen</surname><given-names>C</given-names></string-name>, <string-name><surname>Dudley</surname><given-names>E</given-names></string-name>, <string-name><surname>Mays</surname><given-names>RM</given-names></string-name>, <string-name><surname>Worthington</surname><given-names>ZV</given-names></string-name></person-group>. <year>2004</year>. <article-title>Suppression of serum antibody responses by pertussis toxin after respiratory tract colonization by <italic toggle="yes">Bordetella pertussis</italic> and identification of an immunodominant lipoprotein</article-title>. <source>Infect Immun</source><volume>72</volume>:<fpage>3350</fpage>–<lpage>3358</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.6.3350-3358.2004</pub-id>.<pub-id pub-id-type="pmid">15155640</pub-id></mixed-citation>
              </ref>
              <ref id="B59">
                <label>59</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shumilla</surname><given-names>JA</given-names></string-name>, <string-name><surname>Lacaille</surname><given-names>V</given-names></string-name>, <string-name><surname>Hornell</surname><given-names>TMC</given-names></string-name>, <string-name><surname>Huang</surname><given-names>J</given-names></string-name>, <string-name><surname>Narasimhan</surname><given-names>S</given-names></string-name>, <string-name><surname>Relman</surname><given-names>DA</given-names></string-name>, <string-name><surname>Mellins</surname><given-names>ED</given-names></string-name></person-group>. <year>2004</year>. <article-title><italic toggle="yes">Bordetella pertussis</italic> infection of primary human monocytes alters HLA-DR expression</article-title>. <source>Infect Immun</source><volume>72</volume>:<fpage>1450</fpage>–<lpage>1462</lpage>. <pub-id pub-id-type="doi">10.1128/IAI.72.3.1450-1462.2004</pub-id>.<pub-id pub-id-type="pmid">14977950</pub-id></mixed-citation>
              </ref>
              <ref id="B60">
                <label>60</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martino</surname><given-names>A</given-names></string-name>, <string-name><surname>Volpe</surname><given-names>E</given-names></string-name>, <string-name><surname>Auricchio</surname><given-names>G</given-names></string-name>, <string-name><surname>Colizzi</surname><given-names>V</given-names></string-name>, <string-name><surname>Baldini</surname><given-names>PM</given-names></string-name></person-group>. <year>2006</year>. <article-title>Influence of pertussis toxin on CD1a isoform expression in human dendritic cells</article-title>. <source>J Clin Immunol</source><volume>26</volume>:<fpage>153</fpage>–<lpage>159</lpage>. <pub-id pub-id-type="doi">10.1007/s10875-006-9009-3</pub-id>.<pub-id pub-id-type="pmid">16598657</pub-id></mixed-citation>
              </ref>
              <ref id="B61">
                <label>61</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weiss</surname><given-names>AA</given-names></string-name>, <string-name><surname>Falkow</surname><given-names>S</given-names></string-name></person-group>. <year>1982</year>. <article-title>Plasmid transfer to <italic toggle="yes">Bordetella pertussis</italic>: conjugation and transformation</article-title>. <source>J Bacteriol</source><volume>152</volume>:<fpage>549</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1128/jb.152.1.549-552.1982</pub-id>.<pub-id pub-id-type="pmid">6288667</pub-id></mixed-citation>
              </ref>
              <ref id="B62">
                <label>62</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mooi</surname><given-names>FR</given-names></string-name>, <string-name><surname>Van Loo</surname><given-names>IHM</given-names></string-name>, <string-name><surname>Van Gent</surname><given-names>M</given-names></string-name>, <string-name><surname>He</surname><given-names>Q</given-names></string-name>, <string-name><surname>Bart</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Heuvelman</surname><given-names>KJ</given-names></string-name>, <string-name><surname>De Greeff</surname><given-names>SC</given-names></string-name>, <string-name><surname>Diavatopoulos</surname><given-names>D</given-names></string-name>, <string-name><surname>Teunis</surname><given-names>P</given-names></string-name>, <string-name><surname>Nagelkerke</surname><given-names>N</given-names></string-name>, <string-name><surname>Mertsola</surname><given-names>J</given-names></string-name></person-group>. <year>2009</year>. <article-title><italic toggle="yes">Bordetella pertussis</italic> strains with increased toxin production associated with pertussis resurgence</article-title>. <source>Emerg Infect Dis</source><volume>15</volume>:<fpage>1206</fpage>–<lpage>1213</lpage>. <pub-id pub-id-type="doi">10.3201/eid1508.081511</pub-id>.<pub-id pub-id-type="pmid">19751581</pub-id></mixed-citation>
              </ref>
              <ref id="B63">
                <label>63</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Advani</surname><given-names>A</given-names></string-name>, <string-name><surname>Gustafsson</surname><given-names>L</given-names></string-name>, <string-name><surname>Carlsson</surname><given-names>RM</given-names></string-name>, <string-name><surname>Donnelly</surname><given-names>D</given-names></string-name>, <string-name><surname>Hallander</surname><given-names>HO</given-names></string-name></person-group>. <article-title>Clinical outcome of pertussis in Sweden: association with pulsed-field gel electrophoresis profiles and serotype</article-title>. <source>APMIS</source><volume>115</volume>:<fpage>736</fpage>–<lpage>742</lpage>. <pub-id pub-id-type="doi">10.1111/j.1600-0463.2007.apm_628.x</pub-id>.</mixed-citation>
              </ref>
              <ref id="B64">
                <label>64</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>King</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Van Der Lee</surname><given-names>S</given-names></string-name>, <string-name><surname>Mohangoo</surname><given-names>A</given-names></string-name>, <string-name><surname>Van Gent</surname><given-names>M</given-names></string-name>, <string-name><surname>Van Der Ark</surname><given-names>A</given-names></string-name>, <string-name><surname>Van De Waterbeemd</surname><given-names>B</given-names></string-name></person-group>. <year>2013</year>. <article-title>Genome-wide gene expression analysis of <italic toggle="yes">Bordetella pertussis</italic> isolates associated with a resurgence in pertussis: elucidation of factors involved in the increased fitness of epidemic strains</article-title>. PLoS One <volume>8</volume>:<elocation-id>e66150</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0066150</pub-id>.</mixed-citation>
              </ref>
              <ref id="B65">
                <label>65</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Andreasen</surname><given-names>C</given-names></string-name>, <string-name><surname>Powell</surname><given-names>DA</given-names></string-name>, <string-name><surname>Carbonetti</surname><given-names>NH</given-names></string-name></person-group>. <year>2009</year>. <article-title>Pertussis toxin stimulates IL-17 production in response to <italic toggle="yes">Bordetella pertussis</italic> infection in mice</article-title>. <source>PLoS One</source><volume>4</volume>:<elocation-id>e7079</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0007079</pub-id>.<pub-id pub-id-type="pmid">19759900</pub-id></mixed-citation>
              </ref>
              <ref id="B66">
                <label>66</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lee</surname><given-names>GM</given-names></string-name>, <string-name><surname>Lett</surname><given-names>S</given-names></string-name>, <string-name><surname>Schauer</surname><given-names>S</given-names></string-name>, <string-name><surname>Lebaron</surname><given-names>C</given-names></string-name>, <string-name><surname>Murphy</surname><given-names>TV</given-names></string-name>, <string-name><surname>Rusinak</surname><given-names>D</given-names></string-name>, <string-name><surname>Lieu</surname><given-names>TA</given-names></string-name></person-group>. <year>2004</year>. <article-title>Societal costs and morbidity of pertussis in adolescents and adults</article-title>. Clin Infect Dis <volume>39</volume>:<fpage>1572</fpage>–<lpage>1580</lpage>.</mixed-citation>
              </ref>
              <ref id="B67">
                <label>67</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cherry</surname><given-names>JD</given-names></string-name></person-group>. <year>2016</year>. <article-title>Pertussis in young infants throughout the world</article-title>. <source>Clin Infect Dis</source><volume>63</volume>:<fpage>S119</fpage>–<lpage>S122</lpage>. <pub-id pub-id-type="doi">10.1093/cid/ciw550</pub-id>.<pub-id pub-id-type="pmid">27838663</pub-id></mixed-citation>
              </ref>
              <ref id="B68">
                <label>68</label>
                <mixed-citation publication-type="working-paper"><person-group person-group-type="author"><string-name><surname>Hiramatsu</surname><given-names>Y</given-names></string-name>, <string-name><surname>Suzuki</surname><given-names>K</given-names></string-name>, <string-name><surname>Nishida</surname><given-names>T</given-names></string-name>, <string-name><surname>Onoda</surname><given-names>N</given-names></string-name>, <string-name><surname>Satoh</surname><given-names>T</given-names></string-name>, <string-name><surname>Akira</surname><given-names>S</given-names></string-name>, <string-name><surname>Ikawa</surname><given-names>M</given-names></string-name>, <string-name><surname>Ikeda</surname><given-names>H</given-names></string-name>, <string-name><surname>Kamei</surname><given-names>J</given-names></string-name>, <string-name><surname>Derouiche</surname><given-names>S</given-names></string-name>, <string-name><surname>Tominaga</surname><given-names>M</given-names></string-name>, <string-name><surname>Horiguchi</surname><given-names>Y</given-names></string-name></person-group>. <year>2020</year>. <article-title>Lipooligosaccharide, Vag8, and pertussis toxin of <italic toggle="yes">Bordetella pertussis</italic> cooperatively cause coughing in mice</article-title>. <source>bioRxiv</source><ext-link xlink:href="https://www.biorxiv.org/content/10.1101/2020.12.25.424096v1" ext-link-type="uri">https://www.biorxiv.org/content/10.1101/2020.12.25.424096v1</ext-link>.</mixed-citation>
              </ref>
              <ref id="B69">
                <label>69</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bordet</surname><given-names>J</given-names></string-name>, <string-name><surname>Gengou</surname><given-names>O</given-names></string-name></person-group>. <year>1906</year>. <article-title>Le microbe de la coqueluche</article-title>. <source>Les Ann L’Institut Pasteur</source><volume>20</volume>:<fpage>731</fpage>–<lpage>741</lpage>.</mixed-citation>
              </ref>
              <ref id="B70">
                <label>70</label>
                <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Stainer</surname><given-names>DW</given-names></string-name>, <string-name><surname>Scholte</surname><given-names>MJ</given-names></string-name></person-group>. <year>1970</year>. <article-title>A simple chemically defined medium for the production of phase I <italic toggle="yes">Bordetella pertussis</italic></article-title>. <source>J Gen Microbiol</source><volume>63</volume>:<fpage>211</fpage>–<lpage>220</lpage>. <pub-id pub-id-type="doi">10.1099/00221287-63-2-211</pub-id>.<pub-id pub-id-type="pmid">4324651</pub-id></mixed-citation>
              </ref>
              <ref id="B71">
                <label>71</label>
                <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Lomask</surname><given-names>J</given-names></string-name>, <string-name><surname>Larson</surname><given-names>R</given-names></string-name></person-group>. <comment>Cough/sneeze analyzer and method</comment>. <year>2006</year>. <article-title>US patent USOO7104962B2</article-title>. <comment>US patent 7,104,962 B2. Application granted, 12 September 2006</comment>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
